Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Franck M. Andre
Based on 125 articles published since 2007
||||
Expertise Level
The expertise of Franck M. Andre ranks in the
  • Top 0.0039%
  • ... of 253,558 published authors worldwide on Breast Neoplasms
  • ... from 2007 through 2018
  • ... based on contributions to 125 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases André, F   ·   Andre, Franck M   ·   Andre, Fabrice   ·   Andre, F   ·   André, Fabrice
Work Locations
Details
Most likely:    Institut Gustave Roussy      
2017
  • European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · European School of Oncology, Milan, Italy and European School of Oncology, Bellinzona, Switzerland. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Breast Center, Genolier Cancer Center, Genolier, Switzerland. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Fortis Hospital, Kolkata, India. · Medical Oncology Department, Hospital of Prato, Prato, Italy. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center. · METAvivor Research and Support, Annapolis, USA. · Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, Institut Curie, Paris, France. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon. · Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada. · Department of Medical Oncology, Galliera Hospital, Genoa, Italy. · Brustzentrum der Universitat München, Munich, Germany. · Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston. · Advanced Breast Cancer.org, New York, USA. · Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands. · Metastatic Breast Cancer Network US, Inversness, USA. · Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Europa Donna, Nicosia, Cyprus. · European School of Oncology, Milan, Italy and Bellinzona, Switzerland. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco. · Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore. · Indiana University Medical CTR, Indianapolis. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany. · Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Pubmed 28177437
  • European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. Electronic address: · European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Breast Center, Genolier Cancer Center, Genolier, Switzerland. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Fortis Hospital, Kolkata, India. · Medical Oncology Department, Hospital of Prato, Prato, Italy. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center, USA. · METAvivor Research and Support, Annapolis, USA. · Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, Institut Curie, Paris, France. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon. · Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada. · Department of Medical Oncology, Galliera Hospital, Genoa, Italy. · Brustzentrum der Universitat München, Munich, Germany. · Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Advanced BC.org, New York, USA. · Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands. · Metastatic Breast Cancer Network US, Inversness, USA. · Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Europa Donna, Nicosia, Cyprus. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore, USA. · Indiana University Medical CTR, Indianapolis, USA. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, DE, Germany. · Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Pubmed 27927580
  • Department of Medical Oncology, Gustave Roussy, Villejuif, France. · Pubmed 28505221
  • Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France. · Department of Cancer Medicine, Gustave Roussy, Villejuif, France; Inserm U931, Cancer Biomarkers, Université Paris Saclay, Gustave Roussy, Villejuif, France. · Department of Cancer Medicine, Gustave Roussy, Villejuif, France; Inserm U931, Cancer Biomarkers, Université Paris Saclay, Gustave Roussy, Villejuif, France. Electronic address: · Pubmed 28400088
  • German Breast Group GBG Forschungs GmbH, Neu-Isenburg, Germany · Centre for Haematology and Oncology Bethanien, Frankfurt, Germany. · Royal Marsden Hospital and Institute of Cancer Research, London, UK. · National Cancer Center, Goyang-si, South Korea. · Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Chicago, Illinois, USA. · Aichi Cancer Center Hospital, Nagoya, Japan. · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea. · Breast Oncology, NHO Osaka National Hospital, Osaka-city, Japan. · Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Institut Gustave Roussy, Villejuif, France. · Brustzentrum der Universität München (LMU), Munich, Germany. · University of Calgary, Tom Baker Cancer Centre, Calgary, Alberta, Canada. · Pfizer Oncology, Cambridge, Massachussets, USA. · Pfizer Inc., San Diego, California, USA. · Pfizer Inc., Collegeville, Pennsylvania, USA. · Pubmed 28652278
  • Medical Oncology Unit, Azienda Ospedaliero-Universitaria di Parma, Via Gramsci 14, 43126, Parma, Italy. · Institut de Cancerologie de l'Ouest, René Gauducheau, Saint-Herblain, France. · Hospital Gasthuisberg, Leuven, Belgium. · Virginia Cancer Specialists, US Oncology Research, Arlington, VA, USA. · Pontificia Universidade Católica do Rio Grande do Sul School of Medicine, Porto Alegre, Brazil. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Ramon y Cajal University Hospital, Madrid, Spain. · Duke University Medical Center, Durham, NC, USA. · Moffitt Cancer Center, Tampa, FL, USA. · University of Szeged, Szeged, Hungary. · Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, Bordeaux, France. · Novartis Pharma AG, Basel, Switzerland. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Institut Gustave Roussy, Villejuif, France. · Pubmed 28183331
  • Medical Oncology Department, Institut Curie, PSL Research University, Paris, France. · Biostatistics Department, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille, Marseille. · Medical Oncology Department, Centre Paul Strauss, Strasbourg. · Medical Oncology Department, Gustave Roussy INSERM Unit U981, Université Paris Sud, Villejuif. · Medical Oncology Department, Institut Claudius Regaud, IUCT, Toulouse. · Medical Oncology Department, Centre François Baclesse, Caen. · Medical Oncology Department, Centre Antoine Lacassagne, Nice. · Medical Oncology Department, Institut du Cancer de Montpellier, Montpellier. · Medical Oncology Department, Centre Oscar Lambret, Lille. · Medical Oncology Department, Institut Curie, Saint Cloud. · Medical Oncology Department, Centre Léon Bérard, Lyon. · Medical Oncology Department, Centre Eugène Marquis, Rennes. · Medical Oncology Department, Institut de Cancérologie de l'Ouest, ICO Angers Nantes. · Medical Oncology Department, Institut Jean Godinot, Reims. · Medical Oncology Department, Centre Jean Perrin, Clermont Ferrand. · Medical Oncology Department, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris, Université Pierre et Marie Curie, Paris. · Centre Armoricain de Radiothérapie d'Imagerie médicale et d'Oncologie, Plérin. · Centre Catherine de Sienne, Nantes. · Pathology Department, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille, Marseille. · Aix-Marseille Université, Marseille. · R&D UNICANCER, UCBG, Paris. · Department of Medical Oncology, Centre de Recherche en Cancé rologie de Marseille, Institut Paoli-Calmettes, Marseille, France. · Pubmed 28177480
  • Breast Cancer Program, Istituto Europeo di Oncologia, Milano, Italy. · Breast Oncology Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA. · Department of Surgery, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria. · Klinik St. Anna, Luzern, Switzerland. · German Breast Group, Neu-Isenburg, Germany. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA. · Department of Medical Oncology, Institut Jules Bordet, UniversitÕ Libre de Bruxelles, Brussels, Belgium. · Tumor and Breast Center ZeTuP, St. Gallen. · Breast Center, Kantonsspital St. Gallen, St. Gallen, Switzerland. · Institut de Cancérologie Gustave Roussy, Villejuif, France. · Memorial Sloan Kettering Cancer Center, New York, USA. · Karolinska Institute and University Hospital, Stockholm, Sweden. · University of Bordeaux, Bordeaux, France. · Universitäts-Frauenklinik Tübingen, Tübingen, Germany. · Champalimaud Cancer Centre, Lisbon, Portugal. · Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, USA. · Hospital Universitario 12 de Octubre, Madrid, Spain. · Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK. · Institut für Pathologie, Charité Universitätsmedizin Berlin, Berlin, Germany. · Azienda Usl Toscana Centro, Prato, Italy. · Rigshospitalet, Copenhagen, Denmark. · Peter McCallum Cancer Centre, Melbourne, Australia. · Marmara University School of Medicine, Istanbul, Turkey. · University of Toronto, Mount Sinai Hospital, Toronto, Canada. · University of Munich, München, Germany. · Comprehensive Cancer Center, University of Michigan, Ann-Arbor, USA. · National Taiwan University Hospital, Taipei, Taiwan. · University of Ulm, Ulm, Germany. · The National Cancer Institute, Cairo University, Cairo, Egypt. · Medical University of Gdansk, Gdansk, Poland. · Hospital Affiliated to Military Medical Science, Beijing, China. · Institute of Clinical Sciences, Sahlgrenska Academy, Sahlgrensky University Hospital, Gothenburg, Sweden. · Baylor College of Medicine, Houston, USA. · Institute of Oncology Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland. · Sunnybrook Odette Cancer Center, University of Toronto, Toronto, Canada. · National Cancer Center, Ilsandong-gu, Goyang-si, Gyeonggi-do, Korea. · Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · LKH Salzburg, Paracelsus Medical University Clinics, Salzburg, Austria. · N.N. Petrov Research Institute of Oncology, St. Petersburg, Russian Federation. · Fudan University Cancer Hospital, Shanghai, China. · The Royal Marsden, Sutton, Surrey, UK. · Graduate School of Medicine Kyoto University, Sakyo-ku, Kyoto City, Japan. · Breast Cancer Now Research Centre, The Institute of Cancer Research, London, UK. · University of Milan, Milan. · Istituto Europeo di Oncologia, Milan, Italy. · Hamamatsu Oncology Center, Hamamatsu, Japan. · McMaster University, Hamilton, Canada. · National Cancer Center, Chaoyang District, Beijing, China. · Pubmed 28838210
2016
  • Université Paris Saclay, institut Gustave-Roussy, département de médecine oncologique, Inserm U981, 114, rue Edouard-Vaillant, 94800 Villejuif, France. Electronic address: · Centre Léon-Bérard, département de cancérologie médicale, 28, rue Laënnec, 69008 Lyon cedex 08, France. · Université de recherche Paris, sciences et lettres, institut Curie, 26, rue d'Ulm, 75005 Paris, France. · Hôpital Saint-Louis, 1, avenue Claude-Vellefaux, 75010 Paris, France. · Institut Curie, Saint-Cloud, 35, rue Dailly, 92210 Saint-Cloud, France; Université Versailles-Saint-Quentin, 78180 Montigny-le-Bretonneux, France. · Université de Bordeaux, institut Bergonie, 229, cours de l'Argonne, 33000 Bordeaux, France. · Hôpital Tenon, université Paris-Sorbonne, Inserm U938, 4, rue de la Chine, 75020 Paris, France. · Institut universitaire du cancer-Toulouse oncopole, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France. · Centre Armoricain d'oncologie, Cario, 21, rue du Vieux-Séminaire, 22000 Saint-Brieuc, France. · Université de Montpellier, institut du cancer, IRCM U1194, 34298 Montpellier, France. · Institut de cancérologie de la Loire, 108 B, avenue Albert-Raimond, 42270 Saint-Priest-en-Jarez, France. · R&D Unicancer, 101, rue de Tolbiac, 75013 Paris, France. · Université Aix-Marseille, institut Paoli-Calmettes, Inserm U1068, 232, boulevard de Sainte-Marguerite, 13009 Marseille, France. · Université de Bourgogne, centre Georges-François-Leclerc, 1, rue du Pr-Marion, 21000 Dijon, France. · Centre Jean-Bernard, 9, rue Beauverger, 72000 Le Mans, France. · Université de Strasbourg, centre Paul-Strauss, 3, rue de la Porte-de-l'Hôpital, 67000 Strasbourg, France. · Université d'Auvergne, centre Jean-Perrin, 58, rue Montalembert, 63000 Clermont-Ferrand, France. · Institut d'oncologie de l'Ouest, Inserm U892, IRT-UN, 8, quai Moncousu, 44007 Nantes cedex, France. · Centre François-Baclesse, 3, avenue du Général-Harris, 14000 Caen, France. · Centre Catherine-de-Sienne, 2, rue Éric-Tabarly, 44202 Nantes, France. · CHU de Limoges, service d'oncologie médicale, 22, avenue Martin-Luther-King, 87000 Limoges, France. · Institut Sainte-Catherine, 250, chemin de Baignes-Pieds, 84918 Avignon cedex 9, France. · Ligue nationale contre le cancer, comité du Lot, 28, boulevard Gambetta, 46000 Cahors, France. · Europadonna France, 14, rue Corvisart, 75013 Paris, France. · Université de Lyon, 69000 Lyon, France; Université Lyon 1, 69100 Villeurbanne, France; Centre de recherche en cancérologie de Lyon, Inserm U1052, CNRS UMR5286, 69000 Lyon, France; Centre Léon-Bérard, 69008 Lyon, France. · Registre de Côte d'Or, centre Georges-François-Leclerc, 1, rue du Pr-Marion, 21000 Dijon, France. · Institut Gustave-Roussy, département d'imagerie médicale, 114, rue Edouard-Vaillant, 94800 Villejuif, France. · Université Paris Saclay, institut Gustave-Roussy, département de médecine oncologique, Inserm U981, 114, rue Edouard-Vaillant, 94800 Villejuif, France. · Université de recherche Paris, sciences et lettres, institut Curie, 26, rue d'Ulm, 75005 Paris, France; Institut Curie, Saint-Cloud, 35, rue Dailly, 92210 Saint-Cloud, France; Université Versailles-Saint-Quentin, 78180 Montigny-le-Bretonneux, France. · Pubmed 27473920
  • Department of Biostatistics, International Drug Development Institute (IDDI), Louvain La Neuve, Belgium · Division of Hematology-Oncology, University of California, Los Angeles (UCLA), Los Angeles, USA. · Department of Medical Oncology, Institut Gustave Roussy, Université Paris Sud, Villejuif, France. · Department of Breast Oncology, Beijing 307 Hospital of PLA, Beijing, China. · Department of Drug Development, Sarah Cannon Research Institute, Nashville, USA. · Department of Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan. · Breast Surgery Clinic, Isarklinikum München, Munich, Germany. · Department of Scientific Development, Translational Research in Oncology (TRIO), Edmonton, Canada. · Pubmed 26861602
  • Department of Obstetrics and Gynecology, Brustzentrum der Universität München, München (LMU), Germany · Pfizer Inc, New York, USA. · Department of Molecular Oncology, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Department of Medical Oncology, Thomas Jefferson University, Philadelphia, USA. · Department of Medicine, National Cancer Center, Goyang-si, Korea. · Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. · Department of Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia. · Department of Medicine, Sunnybrook Odette Cancer Centre, Toronto, Canada. · Department of Transfusion, Aichi Cancer Center Hospital, Nagoya, Japan. · Pfizer Inc, Cambridge, USA. · Department of Oncology, German Breast Group Forschungs GmbH, Neu-Isenburg, Germany. · Pubmed 27029704
  • INSERM Unit U981, Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Centre Léon Bérard, Inserm U1052, Lyon, France. · Biostatistics Department, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. · Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Nantes, France. · Department of Medical Oncology, Gustave Roussy, Villejuif, France. · Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre, France. · Drug Development Department (DITEP), Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Centre François Baclesse, Caen, France. · R&D UNICANCER, Paris, France. · Bioinformatics core facility, Gustave Roussy, Villejuif, France. · Department of Medical Biology and Pathology, Translational research laboratory and biobank, Gustave Roussy, Villejuif, France. · Department of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy. · Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · Department of Medical Oncology, Institut Curie, Paris & Saint-Cloud, France. · Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France. · Department of Clinical Research, Centre Antoine Lacassagne, Nice, France. · Department of Medical Oncology, Institut du Cancer de Montpellier, Montpellier, France. · Department of Medical Oncology, Centre Oscar Lambret, Lille, France. · Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France. · Department of Medical Oncology, Centre Henri Becquerel, Rouen, France. · Department of Medical Oncology, Centre Eugène Marquis, Rennes, France. · Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France. · Department of Medical Oncology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. · UNICANCER Biobanking Center, Centre Léon Bérard, Lyon, France. · Department of Medical Oncology, Institut Bergonié, Université de Bordeaux, INSERM U916, Bordeaux, France. · EA7285, Versailles-Saint-Quentin-en-Yvelines University, Montigny-le-Bretonneux, France. · Pubmed 28027327
  • Gustave Roussy, Université Paris-Saclay, Department of Medical Oncology, Villejuif, F-94805, France. Electronic address: · Gustave Roussy, Université Paris-Saclay, Department of Biostatistics, Epidemiology and Health Economics, Villejuif, F-94805, France; INSERM U1018, CESP Centre for Research in Epidemiology and Population Health, Université Paris-Sud, Université Paris-Saclay, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, Department of Surgery, Villejuif, F-94805, France. · Gustave Roussy, Université Paris-Saclay, Department of Supportive Care, Villejuif, F-94805, France. · Gustave Roussy, Université Paris-Saclay, Department of Medical Oncology, Villejuif, F-94805, France. · Gustave Roussy, Université Paris-Saclay, Department of Pathology, Villejuif, F-94805, France. · Gustave Roussy, Université Paris-Saclay, Department of Radiation Therapy, Villejuif, F-94805, France. · Gustave Roussy, Université Paris-Saclay, Department of Radiology, Villejuif, F-94805, France. · Gustave Roussy, Université Paris-Saclay, Department of Medical Information, Villejuif, F-94805, France. · Pubmed 27569041
  • INSERM Unit U981, Gustave Roussy, Villejuif, France. Faculté de Médecine, Kremlin-Bicêtre, Université Paris Sud, France. · Department of Medical Biology and Pathology, Translational Research Laboratory and BioBank, Gustave Roussy, Villejuif, France. · Biostatistics Department, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. · INSERM Unit U981, Gustave Roussy, Villejuif, France. Drug Development Department (DITEP), Gustave Roussy, Villejuif, France. · Bioinformatics Core Facility, Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Nantes, France. · Department of Medical Oncology, Centre François Baclesse, Caen, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Medical Oncology, Centre Léon Bérard, Inserm U1052, Lyon, France. · R&D, UNICANCER, Paris, France. · INSERM Unit U981, Gustave Roussy, Villejuif, France. Faculté de Médecine, Kremlin-Bicêtre, Université Paris Sud, France. Drug Development Department (DITEP), Gustave Roussy, Villejuif, France. Department of Medical Oncology, Gustave Roussy, Villejuif, France. · INSERM Unit U981, Gustave Roussy, Villejuif, France. Department of Medical Biology and Pathology, Translational Research Laboratory and BioBank, Gustave Roussy, Villejuif, France. · INSERM Unit U981, Gustave Roussy, Villejuif, France. Faculté de Médecine, Kremlin-Bicêtre, Université Paris Sud, France. Department of Medical Oncology, Gustave Roussy, Villejuif, France. · INSERM Unit U981, Gustave Roussy, Villejuif, France. · Pubmed 27535334
  • a Department of Medical Oncology , Georges François Leclerc Center , Dijon , France. · b Institut National de la Santé et de la Recherche Médicale, Avenir Team INSERM, CRI-866 University of Burgundy , Dijon , France. · c Institut National de la Santé et de la Recherche Médicale, U1015, Equipe labellisée Ligue Nationale Contre le Cancer, Institut Gustave Roussy , Villejuif , France. · d Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus , Villejuif , France. · e Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers , Paris , France. · f INSERM, U1138 , Paris , France. · g Université Paris Descartes, Sorbonne Paris Cité , Paris , France. · h University of Paris Sud XI , Villejuif , France. · i Center of Clinical Investigations in Biotherapies of Cancer (CICBT) , Villejuif , France. · j Center Jean Perrin, EA 4677 Clermont-Ferrand , Clermont-Ferrand , France. · k ERTICa, EA 4677 University of Auvergne , Clermont-Ferrand , France. · l Department of Pathology and Tumor Biology , Georges François Leclerc Center , Dijon , France. · m Biostatistics and Epidemiology Unit, EA 4184, Centre Georges Francois Leclerc Dijon , France. · n Department of Medical Oncology and Breast Cancer Group , Institut Gustave Roussy , Villejuif , France. · o INSERM U981 Identification of molecular predictors and new targets for cancer treatment , Institut Gustave Roussy , Villejuif , France. · p Pôle de Biologie, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris , Paris , France. · q Karolinska Institute, Department of Women's and Children's Health, Karolinska University Hospital , Stockholm , Sweden. · Pubmed 26979828
  • Department of Surgery, Oncology and Gastroenterology, University of Padova, Via Giustiniani 2, 35121, Padua, Italy. · Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Via Gattamelata 64, 35128, Padua, Italy. · INSERM Unit U981, 114 rue E Vaillant, 94805, Villejuif, France. · Gustave Roussy, 114 rue E Vaillant, 94805, Villejuif, France. · Univ. Paris Sud, 63 rue Gabriel Péri, 94270, Le Kremlin-Bicêtre, France. · BGI-Shenzhen, Shenzhen, 518083, China. · Department of Medical Biology and Pathology, Gustave Roussy, 114 rue E Vaillant, 94805, Villejuif, France. · Laboratory of Translational Research and Biobank, Gustave Roussy, 114 rue E Vaillant, 94805, Villejuif, France. · Department of Medical Oncology, Gustave Roussy, 114 rue E Vaillant, 94805, Villejuif, France. · INSERM Unit U981, 114 rue E Vaillant, 94805, Villejuif, France. · Gustave Roussy, 114 rue E Vaillant, 94805, Villejuif, France. · Pubmed 26907767
  • Gustave Roussy, INSERM U981, Univ Paris-Sud, F 94805 Villejuif, France. · IRCIV, Univ Paris-Sud, F 94805 Villejuif, France. · Department of Biopathology, Gustave Roussy, F 94805 Villejuif, France. · Imaging and Cytometry Platform, Gustave Roussy, F 94805 Villejuif, France. · Faculté de Pharmacie, Université de Picardie Jules Vernes, 80000 Amiens, France. · Pubmed 26575022
2015
  • Equipe 11 labellisée Ligue contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. · INSERM, U1138, Paris, France. · Université Paris Descartes/Paris V, Sorbonne, Paris, France. · Université Pierre et Marie Curie/Paris VI, Paris, France. · Metabolomics and Cell Biology Platforms, Gustave Roussy Comprehensive Cancer Institute, Villejuif, France. · Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France. · Department of Women's and Children's Health, Karolinska University Hospital, Stockholm, Sweden. · Gustave Roussy Comprehensive Cancer Institute, Villejuif, France. · University of Paris Sud/Paris XI, Le Kremlin-Bicêtre, France. · INSERM, U1015, Villejuif, France. · Center of Clinical Investigations in Biotherapies of Cancer 507 (CICBT 507), Villejuif, France. · Pubmed 26444637
  • Department of Medical Oncology, Gustave Roussy and Université Paris Sud, 94800 Villejuif, France. · INSERM Unit U981, Gustave Roussy and Université Paris Sud, 94800 Villejuif, France. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, East Melbourne, VIC 3002, Australia. · Department of Biostatistics and Epidemiology, Gustave Roussy and Université Paris Sud, 94800 Villejuif, France. · Department of Medical Oncology and INSERM U916, Institut Bergonié, 229 Cours de l'Argonne, 33000, Bordeaux, France. · Pubmed 26196250
  • Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan. · Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · INSERM Unit U981, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · INSERM Unit U981, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Medical Oncology and INSERM Unit U981, Gustave Roussy Cancer Campus, 114 Rue Edouard Vaillant, Villejuif, 94800, France. · Pubmed 26059247
  • Department of Medical Oncology, Gustave Roussy Institute, 114 rue E. Vaillant, 94800 Villejuif, France. · INSERM Unit UMR981, Gustave Roussy Institute, 114 rue E. Vaillant, 94800 Villejuif, France. · Pubmed 25781576
  • Institut Gustave-Roussy, 39 rue Camille Desmoulins, 94805, Villejuif, France, · Pubmed 25677745
  • University of California, Los Angeles (UCLA), Los Angeles, CA, USA. Electronic address: · Department of Medical Oncology, Institut Gustave Roussy, Université Paris Sud, Villejuif, France. · Beijing 307 Hospital of PLA, Beijing, China. · Department of Breast Surgery, Cancer Hospital of Fudan University, Shanghai, China. · Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil. · Instituto Nacional de Enfermedades Neoplasicas, Surquillo, Lima, Peru. · Taipei Veterans General Hospital, National Yang Ming University, Taipei, Taiwan. · Department of Medical Oncology, Tumor Hospital of Harbin Medical University, Harbin, China. · Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, China. · Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China. · Department of Medical Oncology, University of Pretoria, Gauteng, South Africa. · Sarah Cannon Research Institute, Nashville, Tennessee, USA. · Department of Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan. · International Drug Development Institute, Louvain La Neuve, Belgium. · Translational Research in Oncology (TRIO), Paris, France. · Translational Research in Oncology (TRIO), Edmonton, Canada. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Novartis Pharma AG, Basel, Switzerland. · University of California, Los Angeles (UCLA), Los Angeles, CA, USA. · Pubmed 26092818
  • Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy. · Department of Medical Biology and Pathology, Gustave Roussy, Villejuif, France. · Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy. · INSERM, Unit U981, Gustave Roussy, Villejuif Department of Medical Oncology, Gustave Roussy, Villejuif. · INSERM, Unit U981, Gustave Roussy, Villejuif Department of Medical Oncology, Gustave Roussy, Villejuif Université Paris Sud, Villejuif, France. · INSERM, Unit U981, Gustave Roussy, Villejuif · Pubmed 25995301
  • Gustave Roussy Cancer Campus, Villejuif, France. INSERM, U1138, Paris, France. Équipe 11 Labellisée par la Ligue Nationale Contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. Université Paris Descartes, Sorbonne Paris Cité, Paris, France. Université Pierre et Marie Curie, Paris, France. · Gustave Roussy Cancer Campus, Villejuif, France. INSERM, U1138, Paris, France. Équipe 11 Labellisée par la Ligue Nationale Contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. Université Paris Descartes, Sorbonne Paris Cité, Paris, France. Université Pierre et Marie Curie, Paris, France. Suzhou Institute of Systems Medicine, Suzhou, Jiangsu, China. Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. · Gustave Roussy Cancer Campus, Villejuif, France. INSERM, U1138, Paris, France. Équipe 11 Labellisée par la Ligue Nationale Contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. Faculté de Médecine, Université Paris-Saclay, Kremlin-Bicêtre, France. · Regina Elena National Cancer Institute, Rome, Italy. · Gustave Roussy Cancer Campus, Villejuif, France. INSERM, U1138, Paris, France. Équipe 11 Labellisée par la Ligue Nationale Contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France. · Gustave Roussy Cancer Campus, Villejuif, France. INSERM, U1138, Paris, France. Équipe 11 Labellisée par la Ligue Nationale Contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. · Gustave Roussy Cancer Campus, Villejuif, France. INSERM, U1138, Paris, France. Équipe 11 Labellisée par la Ligue Nationale Contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Gustave Roussy Cancer Campus, Villejuif, France. INSERM, U1015, Villejuif, France. Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France. · Department of Hematology, Oncology, and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy. · Italian National Research Council, Institute for Photonics and Nanotechnology, Rome, Italy. · Genomics and Immunoregulation, Life and Medical Science Center Institute, University of Bonn, Germany. · Gustave Roussy Cancer Campus, Villejuif, France. INSERM, U981, Villejuif, France. · Université Paris Sorbonne Cité, UMRS 775, INSERM, Paris, France. INSERM U1147, Centre de Ressources Biologiques (CRB) EPIGENETIC, Paris, France. · Gustave Roussy Cancer Campus, Villejuif, France. INSERM, U1138, Paris, France. Équipe 11 Labellisée par la Ligue Nationale Contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. Faculté de Médecine, Université Paris-Saclay, Kremlin-Bicêtre, France. Sotio, Prague, Czech Republic. · Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France. Université Bourgogne Franche-Comté, Dijon, France. Centre Georges François Leclerc, Dijon, France. · Department of Life Sciences, University of Siena, Siena, Italy. · Institut du Cerveau et de la Moelle Épinière, ICM CNRS UMR 7225 - INSERM U 1127 - UPMC-P6 UMR S 1127, Équipe Neurogénétique et Physiologie Hôpital de la Pitié-Salpêtrière, 47, Boulevard de l'Hôpital, 75013 Paris, France. · INSERM U1147, Centre de Ressources Biologiques (CRB) EPIGENETIC, Paris, France. Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif Cedex, France. · Faculté de Médecine, Université Paris-Saclay, Kremlin-Bicêtre, France. Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif Cedex, France. · INSERM, U981, Villejuif, France. Department of Breast Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · University of Franche-Comté, INSERM 1098, France. · Gustave Roussy Cancer Campus, Villejuif, France. INSERM, U981, Villejuif, France. Department of Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France. Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · Regina Elena National Cancer Institute, Rome, Italy. Department of Biology, University of Rome "Tor Vergata," Rome, Italy. · Université Paris Sorbonne Cité, UMRS 775, INSERM, Paris, France. INSERM U1147, Centre de Ressources Biologiques (CRB) EPIGENETIC, Paris, France. Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France. · Gustave Roussy Cancer Campus, Villejuif, France. Faculté de Médecine, Université Paris-Saclay, Kremlin-Bicêtre, France. INSERM, U1015, Villejuif, France. Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France. · Gustave Roussy Cancer Campus, Villejuif, France. INSERM, U1138, Paris, France. Équipe 11 Labellisée par la Ligue Nationale Contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. Université Paris Descartes, Sorbonne Paris Cité, Paris, France. Université Pierre et Marie Curie, Paris, France. Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France. Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France. Karolinska Institute, Department of Women's and Children's Health, Karolinska University Hospital, 17176 Stockholm, Sweden. · Pubmed 26516201
  • a Department of Medical Oncology, Georges François Leclerc Center ; Dijon , France. · b Institut National de la Santé et de la Recherche Médicale; U1015, Equipe labellisée Ligue Nationale Contre le Cancer; Institut Gustave Roussy , Villejuif , France. · c Centre Jean Perrin, EA 4677 Clermont-Ferrand ; Clermont-Ferrand , France. · d ERTICa; EA 4677 University of Auvergne ; Clermont-Ferrand , France. · e Equipe 11 labellisée pas la Ligue Nationale contre le Cancer; Centre de Recherche des Cordeliers ; Paris , France. · f Metabolomics and Cell Biology Platforms; Gustave Roussy Cancer Campus ; Villejuif , France. · g Biostatistics and Epidemiology Unit; EA 4184; Centre Georges Francois Leclerc Dijon , France. · h Université Paris Descartes; Sorbonne Paris Cité ; Paris , France. · i Department of Pathology and Tumor Biology; Georges François Leclerc Center ; Dijon , France. · j Institut National de la Santé et de la Recherche Médicale; Avenir Team INSERM; CRI-866 University of Burgundy , Dijon , France. · k Department of Medical Oncology and Breast Cancer Group; Institut Gustave Roussy , Villejuif , France. · l INSERM U981 "Identification of molecular predictors and new targets for cancer treatment"; Institut Gustave Roussy ; Villejuif , France. · m University of Paris Sud XI , Villejuif , France. · n Center of Clinical Investigations in Biotherapies of Cancer (CICBT) , Villejuif , France. · o Pôle de Biologie; Hôpital Européen Georges Pompidou; Assistance Publique-Hôpitaux de Paris ; Paris , France. · p INSERM; U1138 , Paris , France. · Pubmed 26506894
  • Centre Hospitalier Universitaire Sart Tilman Liège and Liège University, Domaine Universitaire du Sart Tilman, B35, 4000, Liège, Belgium. · University Hospitals Leuven, Herestraat 49, box 7003, B-3000, Leuven, Belgium. · Navigant Consulting, Inc, Woolgate Exchange, 25 Basinghall Street, EC2V 5HA, London, UK. · Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ, 07936-1080, USA. · Navigant Consulting, Inc, Woolgate Exchange, 25 Basinghall Street, EC2V 5HA, London, UK. · Novartis Farma S.p.A., Largo Umberto Boccioni 1, I-21040, Origgio, VA, Italy. · Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ, 07936-1080, USA. · Wellmera AG, Basel, Switzerland. · Institut Gustave Roussy, 39 Rue C. Desmoulins, 94805, Villejuif, France. · Pubmed 26498283
  • Center for Biological Sequence Analysis, Department of Systems Biology, Technical University of Denmark, Kemitorvet 8, DK-2800, Lyngby, Denmark. · Center for Biological Sequence Analysis, Department of Systems Biology, Technical University of Denmark, Kemitorvet 8, DK-2800, Lyngby, Denmark. · Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, 72 Huntley Street, London, WC1E 6BT, UK. · Center for Biological Sequence Analysis, Department of Systems Biology, Technical University of Denmark, Kemitorvet 8, DK-2800, Lyngby, Denmark. · NNF Center for Protein Research, University of Copenhagen, Blegdamsvej 3B, DK-2200, Copenhagen, Denmark. · Center for Biological Sequence Analysis, Department of Systems Biology, Technical University of Denmark, Kemitorvet 8, DK-2800, Lyngby, Denmark. · Center for Biological Sequence Analysis, Department of Systems Biology, Technical University of Denmark, Kemitorvet 8, DK-2800, Lyngby, Denmark. · Inserm Unit U981, Gustave Roussy, Villejuif, France. · Inserm Unit U981, Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Gustave Roussy, Villejuif, France. · Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, 72 Huntley Street, London, WC1E 6BT, UK. · Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, 72 Huntley Street, London, WC1E 6BT, UK. · Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, 72 Huntley Street, London, WC1E 6BT, UK. · Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, 72 Huntley Street, London, WC1E 6BT, UK. · Cancer Research UK London Research Institute, London, UK. · Inserm Unit U981, Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Gustave Roussy, Villejuif, France. · Center for Biological Sequence Analysis, Department of Systems Biology, Technical University of Denmark, Kemitorvet 8, DK-2800, Lyngby, Denmark. · Children's Hospital Informatics Program at the Harvard-MIT Division of Health Sciences and Technology (CHIP@HST), Harvard Medical School, Boston, USA. · Center for Biological Sequence Analysis, Department of Systems Biology, Technical University of Denmark, Kemitorvet 8, DK-2800, Lyngby, Denmark. · Pubmed 26429708
  • Institut National de la Santé et de la Recherche Médicale (INSERM) U981, Institut de cancérologie Gustave Roussy, Villejuif, F-94800, France; Department of Medical Oncology, S. Andrea Hospital, University of Rome « Sapienza », Rome, Italy. · Institut National de la Santé et de la Recherche Médicale (INSERM) U981, Institut de cancérologie Gustave Roussy, Villejuif, F-94800, France. · Institut National de la Santé et de la Recherche Médicale (INSERM) U981, Institut de cancérologie Gustave Roussy, Villejuif, F-94800, France; Department of Medical Oncology, Institut de cancérologie Gustave Roussy, Villejuif, F-94800, France. Electronic address: · Pubmed 26238439
  • Department of medical oncology, Institut Gustave-Roussy 114, rue Edouard-Vaillant, 94805 Villejuif cedex, France; Inserm U981, Institut Gustave-Roussy 114, rue Edouard-Vaillant, 94805 Villejuif cedex, France. Electronic address: · Department of medical oncology, Institut Gustave-Roussy 114, rue Edouard-Vaillant, 94805 Villejuif cedex, France. · Department of medical oncology, Institut Gustave-Roussy 114, rue Edouard-Vaillant, 94805 Villejuif cedex, France; Inserm U981, Institut Gustave-Roussy 114, rue Edouard-Vaillant, 94805 Villejuif cedex, France. · Pubmed 26118866
  • From the Department of Medical Oncology, Gustave Roussy, Villejuif, France. · Pubmed 25993174
  • Department of Medical Oncology, Gustave Roussy, Villejuif, France; INSERM Unit U981 and Université Paris Sud, Faculté de Medecine Kremlin Bicetre, Kremlin Bicetre, France. Electronic address: · Department of Medical Oncology, Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Institut Bergonie, Bordeaux, France. · Pubmed 25975636
  • Assistance Publique - Hôpitaux de Paris (APHP), Groupe Hospitalier Pitié-Salpétrière, Medical Oncology Department led by Prof. David Khayat, Cancer University Institute, 47 Bd de l'Hôpital, F-75013 Paris, France. · Institut Curie, 26 rue d'Ulm, F-75005 Paris, France. · Institut du Cancer Reims, 38 rue de Courlancy, F-51100 Reims, France. · Centre Georges-François-Leclerc, Département de biologie et de pathologie des Tumeurs, 1 rue du Pr. Marion, F-21034 Dijon, France. · Centre Catherine de Sienne, Service de Chimiothérapie, 2 rue Éric Tabarly, F-44202 Nantes, France. · Institut Gustave Roussy, 39 rue Camilles-Desmoulins, F-94805 Villejuif, France. · Centre Antoine Lacassagne, 33 Avenue de Valombrose, F-06100 Nice, France. Electronic address: · Pubmed 25913287
2014
  • European School of Oncology & Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. Electronic address: · European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Division of Oncology, Institut Multidisciplinaire d'Oncologie, Genolier, Switzerland. · Department of Medical Oncology, Gustave-Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Sandro Pitigliani Oncology Centre, Prato, Italy. · Breast Cancer Clinical Program, Duke Cancer Institute, Durham, USA. · Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. · University Clinic Golnik, Medical Faculty Ljubljana, Ljubljana, Slovenia. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver, Canada. · Departments of Health Services Research and Breast Medical Oncology, UT MD Anderson Cancer Center, Houston, USA. · APHP Tenon, IUC-UPMC, Francilian Breast Intergroup, Arome, Paris, France. · Program of Breast Health, European Institute of Oncology, Milan, Italy. · Brustzentrum der Universität München, Munich, DE, USA. · Screening and Test Evaluation Program, School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia. · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Europa Donna Cyprus, Nicosa, Cyprus. · Advanced BC.org, New York, USA. · University of Michigan Medical School and School of Public Health, Ann Arbor, USA. · Europa Donna Sweden & Bröstcancerföreningarnas Riksorganisation, BRO, Sundbyberg, Sweden. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Department Medical Oncology, Division of Women's Cancers, Dana-Farber Cancer Institute, Boston, USA. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Brussels, Belgium. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Indiana University Medical CTR, Indianapolis, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, DE, Germany. · Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Radiotherapy, Clinique des Grangettes, Geneva, Switzerland. · Nursing Division, Health Board, Cardiff and Vale University, Cardiff, UK. · Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Pubmed 25244983
  • Department of Medical Oncology, INSERM Unit U981, Université Paris Sud, Institut Gustave Roussy, Villejuif, France. · Winship Cancer Institute of Emory University, Atlanta, GA, USA. · Cerrahpasa Medical Faculty, Department of Medicine, Division of Medical Oncology, Istanbul University, Istanbul, Turkey. · Kyoto University, Sakyo-ku, Kyoto, Japan. · Department of Medical Oncology, Cancer Hospital and Institute, Chinese Academy of Medical Sciences and Peking Union Medical College, Chaoyang District, Beijing, China. · Centre Hospitalier Universitaire du Sart-Tilman, Domaine Universitaire B35, Liège, Belgium. · NHO Osaka National Hospital, Chuou-ku, Osaka, Japan. · Cancer Care Centers of South Texas, San Antonio, TX, USA. · NYU Langone Arena Oncology, Lake Success, NY, USA. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA. · National Cancer Centre Singapore, Singapore. · Oncology Department, Military Hospital, Budapest, Hungary. · Orszagos Onkologiai Intezet, Budapest, Hungary. · Christie Hospital NHS Foundation Trust, Manchester, UK. · Sanatorio de la Providencia, Buenos Aires, Argentina. · Monash Medical Center, Moorabbin Hospital, Bentleigh East, VIC, Australia; Cabrini Brighton Hospital, Brighton, VIC, Australia. · Comprehensive Breast Health Center, RuiJin Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai, China. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Oncology Global Development, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Ospedale San Raffaele Scientific Institute, Milan, Italy. Electronic address: · Pubmed 24742739
  • Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France; INSERM Unit U981, Institut Gustave Roussy, Villejuif, France; Université Paris Sud, le Kremlin Bicêtre, France. Electronic address: · Departement de Cancerologie Medicale, Université Lyon 1, Centre Léon Bérard, Lyon, France. · INSERM Unit U981, Institut Gustave Roussy, Villejuif, France. · Institut de Cancérologie de l'Ouest/René Gauducheau, Nantes Saint Herblain, France. · Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France; INSERM Unit U981, Institut Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Institut Claudius Regaud, Department of Pathology, Toulouse, France. · Department of Translational Research, Institut Gustave Roussy, Villejuif, France. · Centre Léon Bérard, Lyon, France; Université Lyon 1, Lyon, France; ProfileXpert, SFR Lyon-Est, Lyon, France. · Department of Translational Research, Institut Curie, Paris, France. · Molecular Oncology Department, Institut Paoli Calmettes, Marseille, France. · Department of Medical Oncology, Institut Claudius Regaud, Toulouse, France. · Department of Medical Oncology, Institut Paoli Calmettes, Marseille, France. · Department of Medical Oncology, Centre François Baclesse, Caen, France. · Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France. · Department of Medical Oncology, Centre Oscar Lambret, Lille, France. · Department of Medical Oncology, Centre Eugène Marquis, Rennes, France. · Research and Development Unit, UNICANCER, Paris, France. · Department of Biostatistics, Institut Claudius Regaud, Toulouse, France. · Department of Medical Oncology, Institut Bergonié, Université de Bordeaux, INSERM U916, Bordeaux, France. · Pubmed 24508104
  • Institut Gustave-Roussy, Comité de pathologie mammaire, 114, rue Édouard-Vaillant, 94800 Villejuif, France. · Centre Paul-Strauss, Département de médecine, 3 rue de la Porte-de-l'hôpital, 67000 Strasbourg, France. · Chirurgie du sein, 17, rue Pétrarque 75116 Paris, France, Institut Curie, Département de bio-pathologie, 35, rue Dailly, 92210 Saint-Cloud, France. · Institut Curie, Département de bio-pathologie, 35, rue Dailly, 92210 Saint-Cloud, France. · Département de médecine oncologique, Institut Curie, 26, rue d'Ulm 75005 Paris, France. Université Paris Descartes, Paris, France. · Centre azuréen de Cancérologie, 1, place du Docteur Jean-Luc-Broquerie, 06250 Mougins, France. · Université Paris VI-Sorbonne, Hôpital Tenon, 4 rue de la Chine, 75020 Paris, France. · Pubmed 25373691
  • 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. [4] Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. [3] INSERM, U848, Villejuif, France. · 1] INSERM, U848, Villejuif, France. [2] Equipe 11 Labellisée par la Ligue Nationale Contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. [3] Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Department of Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France. [3] Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · Regina Elena National Cancer Institute, Rome, Italy. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U981, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Transgene S.A., Illkirch-Graffenstaden, France. · Laboratory for Genomics and Immunoregulation, Life and Medical Sciences (LIMES), University of Bonn, Bonn, Germany. · Laboratory of Experimental Dermatology, Department of Dermatology, University Hospital Bonn, Bonn, Germany. · Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy. · 1] SIB-Swiss Institute of Bioinformatics, Lausanne, Switzerland. [2] National Center of Competence in Research (NCCR) Molecular Oncology, Institut Suisse de Recherche Expérimentale sur le Cancer (ISREC), School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland. [3] Departement de Formation et Recherche, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. · Department of Pathology, Centre Claudius Regaud, Toulouse, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France. [4] Department of Medical Oncology, Hôpital Pitie Salpetriere, Paris, France. · Department of Medical Oncology, Hôpital Pitie Salpetriere, Paris, France. · Yale School of Medicine, New Haven, Connecticut, USA. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Department of Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Pathology, Jean Perrin Center, EA 4677 ERTICa, University of Auvergne, Clermont-Ferrand, France. · 1] Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France. [2] INSERM, CRI-866 Faculty of Medicine, Dijon, France. [3] University of Burgundy, Dijon, France. · Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. · San Raffaele University and Scientific Institute, Milan, Italy. · 1] Center for Systems Biology, Massachusetts General Hospital, Boston, Massachusetts, USA. [2] Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts, USA. · Transgene S.A., Illkirch-Graffenstaden, France. · CNRS UMR5235, University Montpellier II, Place Eugène Bataillon, Montpellier, France. · Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA. · Queensland Institute of Medical Research, Herston, Queensland, Australia. · 1] Queensland Institute of Medical Research, Herston, Queensland, Australia. [2] School of Medicine, The University of Queensland, Herston, Queensland, Australia. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. [3] Department of Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France. [4] Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. [5] INSERM, U981, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U848, Villejuif, France. [3] Université Paris Descartes, Sorbonne Paris Cité, Paris, France. [4] Metabolomics Platform, Gustave Roussy Cancer Campus, Villejuif, France. [5] Pôle de Biologie, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. [3] Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France. · Pubmed 25344738
  • European School of Oncology & Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal · European School of Oncology, Milan, Italy European School of Oncology, Bellinzona, Switzerland. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Division of Oncology, Institut Multidisciplinaire d'Oncologie, Genolier, Switzerland. · Department of Medical Oncology, Gustave-Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Sandro Pitigliani Oncology Centre, Prato, Italy. · Breast Cancer Clinical Program, Duke Cancer Institute, Durham, USA. · Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. · University Clinic Golnik, Medical Faculty Ljubljana, Ljubljana, Slovenia. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver, Canada. · Departments of Health Services Research and Breast Medical Oncology, UT MD Anderson Cancer Center, Houston, USA. · APHP Tenon, IUC-UPMC, Francilian Breast Intergroup, AROME, Paris, France. · Program of Breast Health, European Institute of Oncology, Milan, Italy. · Brustzentrum der Universität München, Munich, Denmark. · Screening and Test Evaluation Program, School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia. · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Europa Donna Cyprus, Nicosa, Cyprus. · AdvancedBC.org, New York. · University of Michigan Medical School and School of Public Health, Ann Arbor, USA. · Europa Donna Sweden & Bröstcancerföreningarnas Riksorganisation, BRO, Sundbyberg, Sweden. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Department Medical Oncology, Division of Women's Cancers, Dana-Farber Cancer Institute, Boston, USA. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Brussels, Belgium. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco. · Indiana University Medical CTR, Indianapolis, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany. · Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Radiotherapy, Clinique des Grangettes, Geneva, Switzerland. · Nursing Division, Health Board, Cardiff and Vale University, Cardiff, UK. · Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Pubmed 25234545
  • From the Department of Medical Oncology and INSERM Unit U981, Gustave Roussy Cancer Campus, Villejuif, France; Department of Medical Oncology, Centre Paoli-Calmettes, Marseille, France. · Pubmed 24857146
  • Institut Gustave Roussy , Villejuif , France. · Pubmed 24490834
  • Research Laboratory of Pediatrics and Nephrology, Hungarian Academy of Sciences, Budapest, Hungary; Oncogenomic Research Group, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary. · Translational Research Unit, Department of Oncology, Istituto Toscano Tumori, Piazza dell'Ospedale 2, Prato 59100, Italy. · Department of Biochemistry and INSERM U944, University Rene Diderot, Paris 7, Saint Louis Hospital, Assistance Publique Hôpitaux de Paris, Paris, France. · Pathobiochemistry Research Group of Hungarian Academy of Sciences, Semmelweis University, Department of Medicinal Chemistry, 1444, Bp. 8, POB 260, Hungary; Vichem Chemie Research Ltd, 1022, Herman Otto 15, Budapest, Hungary. · Vichem Chemie Research Ltd, 1022, Herman Otto 15, Budapest, Hungary; Department of Pharmaceutical Chemistry, Semmelweis University, Budapest, Hungary. · Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan. · Breast Cancer Translational Laboratory, Université Libre de Bruxelles, Jules Bordet Institute, Brussels, Belgium. · Division of Medical Oncology, San Raffaele - Scientific Institute, Milan, Italy. · The Breakthrough Breast Cancer Research Center, Institute of Cancer Research, London, UK. · Department of Medical Oncology, Institut National de la Santé et de la Recherche Médicale Unit U981, Institut Gustave Roussy, Villejuif, France. · Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Medical Oncology Unit Sandro Pitigliani, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Yale Cancer Center, New Haven, CT, USA. · Translational Research Unit, Department of Oncology, Istituto Toscano Tumori, Piazza dell'Ospedale 2, Prato 59100, Italy. Electronic address: · Pubmed 24462521
  • Breast Cancer Group, Institut Gustave Roussy, Villejuif, France. Electronic address: · Breast Cancer Group, Institut Gustave Roussy, Villejuif, France. · Breast Cancer Group, Institut Gustave Roussy, Villejuif, France; INSERM U981, Institut Gustave Roussy, Villejuif, France. · Breast Cancer Group, Institut Gustave Roussy, Villejuif, France; INSERM U981, Institut Gustave Roussy, Villejuif, France; Université Paris Sud, Le Kremlin Bicêtre, France. · Pubmed 24411195
  • Department of Medical Oncology, INSERM Unit U981, Université Paris Sud, Institut Gustave Roussy, Villejuif, France. · Ospedale San Raffele Scientific Institute, 20132 Milan, Italy. Electronic address: · Pubmed 24988930
2013
  • Institut Gustave-Roussy, unité de recherche UPRES EA 3535, service de pharmacologie et nouveaux traitements des cancers, 94805 Villejuif Cedex, France. · Pubmed 24579341
  • Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. · Pubmed 23258741
  • Department of Medical Oncology, INSERM Unit U981, Paris Sud University, Institut Gustave-Roussy, Villejuif, France. · Pubmed 23658459
2012
  • Department of Medical Oncology and INSERM U981, Institut Gustave Roussy, Villejuif, France. · Pubmed 23012302
  • Department of Medical Oncology, Institute Gustave Roussy, Villejuif, France. · Pubmed 22241898
2010
  • Department of Medical Oncology, Institut Gustave Roussy, France. · Pubmed 20842030
  • CNRS, UMR 8203-Institut Gustave Roussy PR2, 114 rue Edouard Vaillant, Villejuif, France. · Pubmed 20557285
  • Breast Cancer Unit, Department of Medical Oncology, University Paris XI and Institut Gustave Roussy, Villejuif, France. · Pubmed 20975068
  • Department of Breast Medical Oncology, The University of Texas,M.D. Anderson Cancer Center, Houston, Texas, USA. · Pubmed 20421265
2009
  • Breast Medical Oncology Unit, Department of Radiation Therapy, Department of Pathology and Translational Research Unit (UPRES EA03535), Institut Gustave Roussy, University of Paris XI, Villejuif, France. · Pubmed 19939894
  • Institut Gustave Roussy, Villejuif, France. · Pubmed 19775634
  • Breast Cancer Unit, Department of Medical Oncology, Institut Gustave Roussy France, Villejuif, France. · Pubmed 19249242
  • Translational Research Unit, UPRES03535, Paris Sud University, Orsay, France. · Pubmed 19147748
2017
  • Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ. · Pubmed 28777142
2016
  • From the University of Texas M.D. Anderson Cancer Center, Houston (G.N.H.), and Texas Oncology-Baylor Charles A. Sammons Cancer Center and the U.S. Oncology Network, Dallas (J.O.) - all in Texas; Davidoff Center, Rabin Medical Center, Tel Aviv University, Tel Aviv (S.M.S.), and Sheba Medical Center, Ramat Gan (S.P.-S.) - both in Israel; the Sarah Cannon Research Institute (H.A.B., D.Y.), Vanderbilt-Ingram Cancer Center (C.L.A.), and Tennessee Oncology (D.Y.) - all in Nashville; National Cancer Center Singapore, Singapore (Y.-S.Y.); Netherlands Cancer Institute and BOOG Study Center, Amsterdam (G.S.S.); Institut de Cancérologie de l'Ouest/René Gauducheau, Saint-Herblain (M.C.), Institut Gustave Roussy, Université Paris Sud, Villejuif (F.A.), University Hospital of Besançon, Besançon (C.V.), and Centre Léon Bérard, Lyon (T.B.) - all in France; Duke University Medical Center, Durham, NC (K.L.B.); Dana-Farber Cancer Institute, Boston (E.P.W.); University of Ulm, Ulm (W.J.), Onkologische Praxis, Velbert (A.N.), University of Tübingen, Tübingen (E.-M.G.), and Joint Practice for Interdisciplinary Oncology and Hematology, Freiburg (N.M.) - all in Germany; Tom Baker Cancer Centre, Calgary, AB, Canada (S.V.); University of Padua and Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy (P.C.); Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh (D.A.C.); Masaryk Memorial Cancer Institute, Brno, Czech Republic (K.P.); Florida Cancer Specialists-Sarah Cannon Research Institute, Fort Myers (L.L.H.); Breast Cancer Research Centre-Western Australia and Curtin University, Perth, Australia (A.C.); Department of Oncology, Vejle Hospital, Vejle, Denmark (E.J.); Arkhangelsk Clinical Oncology Dispensary, Arkhangelsk, Russia (O.B.); Hospital Universitario Virgen de la Victoria, Institute of Biomedical Research in Málaga, Málaga, Spain (E.A.); Oslo University Hospital, Oslo (E.W.); Virginia Cancer Specialists, Arlington (A.M.F.); Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan (L.-M.T.); Rainier Hematology-Oncology, Northwest Medical Specialties, Puyallup, WA (S.B.); Novartis Pharmaceuticals, East Hanover, NJ (F.X., M.M., C.G., S.H.); and Novartis Pharma, Basel, Switzerland (F.S.). · Pubmed 27717303
  • Charlotte Fribbens, Ben O'Leary, Sarah Hrebien, Isaac Garcia-Murillas, Matthew Beaney, Mitch Dowsett, and Nicholas C. Turner, Institute of Cancer Research; Charlotte Fribbens, Ben O'Leary, Stephen R.D. Johnston, and Nicholas C. Turner, Royal Marsden Hospital; Lucy Kilburn and Judith M. Bliss, The Institute of Cancer Research Clinical Trials and Statistics Unit, London, UK; Massimo Cristofanilli, Thomas Jefferson University, Philadelphia, PA; Fabrice Andre, Institut Gustave Roussy, Villejuif, France; Sherene Loi, University of Melbourne, Melbourne, Australia; Sibylle Loibl, German Breast Group, Neu-Isenburg, Germany; and John Jiang, Cynthia Huang Bartlett, and Maria Koehler, Pfizer, New York, NY. · Charlotte Fribbens, Ben O'Leary, Sarah Hrebien, Isaac Garcia-Murillas, Matthew Beaney, Mitch Dowsett, and Nicholas C. Turner, Institute of Cancer Research; Charlotte Fribbens, Ben O'Leary, Stephen R.D. Johnston, and Nicholas C. Turner, Royal Marsden Hospital; Lucy Kilburn and Judith M. Bliss, The Institute of Cancer Research Clinical Trials and Statistics Unit, London, UK; Massimo Cristofanilli, Thomas Jefferson University, Philadelphia, PA; Fabrice Andre, Institut Gustave Roussy, Villejuif, France; Sherene Loi, University of Melbourne, Melbourne, Australia; Sibylle Loibl, German Breast Group, Neu-Isenburg, Germany; and John Jiang, Cynthia Huang Bartlett, and Maria Koehler, Pfizer, New York, NY. · Pubmed 27269946
  • Fabrice André, Institut Gustav Roussy, INSERM Unit U981, Université Paris Sud, Villejuif, France; Sara Hurvitz and Dennis Slamon, University of California, Los Angeles, Los Angeles, CA; Angelica Fasolo, San Raffaele Scientific Institute, Milan, Italy; Ling-Ming Tseng, National Yang Ming University, Taipei, Taiwan; Guy Jerusalem, University of Liège, Liege, Belgium; Sharon Wilks, Cancer Care Center of South Texas, San Antonio, TX; Ruth O'Regan, University of Wisconsin Carbone Cancer Center, Madison, WI; Claudine Isaacs, Georgetown University, Washington DC; Masakazu Toi, Kyoto University, Sakyo-ku, Kyoto, Japan; Howard Burris, Sarah Cannon Research Institute, Nashville, TN; Wei He, Douglas Robinson, and Markus Riester, Novartis Institutes for BioMedical Research, Cambridge, MA; and Tetiana Taran and David Chen, Novartis Pharmaceuticals Corporation, East Hanover, NJ. · Fabrice André, Institut Gustav Roussy, INSERM Unit U981, Université Paris Sud, Villejuif, France; Sara Hurvitz and Dennis Slamon, University of California, Los Angeles, Los Angeles, CA; Angelica Fasolo, San Raffaele Scientific Institute, Milan, Italy; Ling-Ming Tseng, National Yang Ming University, Taipei, Taiwan; Guy Jerusalem, University of Liège, Liege, Belgium; Sharon Wilks, Cancer Care Center of South Texas, San Antonio, TX; Ruth O'Regan, University of Wisconsin Carbone Cancer Center, Madison, WI; Claudine Isaacs, Georgetown University, Washington DC; Masakazu Toi, Kyoto University, Sakyo-ku, Kyoto, Japan; Howard Burris, Sarah Cannon Research Institute, Nashville, TN; Wei He, Douglas Robinson, and Markus Riester, Novartis Institutes for BioMedical Research, Cambridge, MA; and Tetiana Taran and David Chen, Novartis Pharmaceuticals Corporation, East Hanover, NJ. · Pubmed 27091708
2015
  • From Royal Marsden Hospital, London (N.C.T.); National Cancer Center, Goyang-si, South Korea (J.R.); Institut Gustave Roussy, Villejuif, France (F.A.); Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia (S. Loi); Sunnybrook Odette Cancer Centre, Toronto (S.V.); Aichi Cancer Center Hospital, Nagoya, Japan (H.I.); Brustzentrum der Universität München, Munich (N.H.), and German Breast Group Forschungs, Neu-Isenburg (S. Loibl) - both in Germany; Pfizer, New York (C.H.B., M.K.), La Jolla, CA (K.Z., S.R.), and Milan (C.G.); and Thomas Jefferson University, Philadelphia (M.C.). · Pubmed 26030518
  • Carsten Denkert, Bruno V. Sinn, Berit M. Pfitzner, Wolfgang D. Schmitt, Silvia Darb-Esfahan, Stephan Wienert, Frederick Klauschen, and Manfred Dietel, Charité Universitätsmedizin Berlin; Carsten Denkert, German Cancer Consortium (DKTK); Peter Klare, Praxisklinik and Breast Center; Jens-Uwe Blohmer, St Gertrauden Krankenhaus and Charité Universitätsmedizin; Micheal Untch, Helios Klinikum Berlin-Buch, Berlin; Gunter von Minckwitz, Stephan Gade, Keyur Mehta, and Sibylle Loibl, German Breast Group, Neu-Isenburg; Gunter von Minckwitz, Women's Hospital, University of Frankfurt; Hans Tesch, Bethanien Hospital, Frankfurt; Jan C. Brase, Ralf Kronenwett, Karin Fisch, and Kristin Krappmann, Sividon Diagnostics, Cologne; Ralf Kronenwett, Heinrich-Heine University Düsseldorf, Düsseldorf; Christian Schem, Christian-Albrechts Universität zu Kiel, Kiel; Christoph Salat, Onkologische Schwerpunktpraxis, Munich; Marcus Schmidt, Johannes-Gutenberg Universität Mainz, Mainz; Sherko Kümmel, Kliniken Essen-Mitte, Essen; Peter Sinn, University of Heidelberg, Heidelberg; Christian Jakisch and Sibylle Loibl, Sana Klinikum Offenbach, Offenbach; Toralf Reimer, Klinikum Südstadt, Rostock, Germany; Sherene Loi, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia; Sherene Loi and Christos Sotiriou, Institute Jules Bordet, Brussels, Belgium; and Fabrice André, Institute Gustave Roussy, Villejuif, France. · Carsten Denkert, Bruno V. Sinn, Berit M. Pfitzner, Wolfgang D. Schmitt, Silvia Darb-Esfahan, Stephan Wienert, Frederick Klauschen, and Manfred Dietel, Charité Universitätsmedizin Berlin; Carsten Denkert, German Cancer Consortium (DKTK); Peter Klare, Praxisklinik and Breast Center; Jens-Uwe Blohmer, St Gertrauden Krankenhaus and Charité Universitätsmedizin; Micheal Untch, Helios Klinikum Berlin-Buch, Berlin; Gunter von Minckwitz, Stephan Gade, Keyur Mehta, and Sibylle Loibl, German Breast Group, Neu-Isenburg; Gunter von Minckwitz, Women's Hospital, University of Frankfurt; Hans Tesch, Bethanien Hospital, Frankfurt; Jan C. Brase, Ralf Kronenwett, Karin Fisch, and Kristin Krappmann, Sividon Diagnostics, Cologne; Ralf Kronenwett, Heinrich-Heine University Düsseldorf, Düsseldorf; Christian Schem, Christian-Albrechts Universität zu Kiel, Kiel; Christoph Salat, Onkologische Schwerpunktpraxis, Munich; Marcus Schmidt, Johannes-Gutenberg Universität Mainz, Mainz; Sherko Kümmel, Kliniken Essen-Mitte, Essen; Peter Sinn, University of Heidelberg, Heidelberg; Christian Jakisch and Sibylle Loibl, Sana Klinikum Offenbach, Offenbach; Toralf Reimer, Klinikum Südstadt, Rostock, Germany; Sherene Loi, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia; Sherene Loi and Christos Sotiriou, Institute Jules Bordet, Brussels, Belgium; and Fabrice André, Institute Gustave Roussy, Villejuif, France. · Pubmed 25534375
2014
  • Kathy D. Miller, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN; Reshma L. Mahtani, Sylvester Comprehensive Cancer Center, Miami, FL; Kathy S. Albain, Loyola University Chicago Stritch School of Medicine, Maywood, IL; Liang Fang, Glenn Michelson, Genentech, South San Francisco, CA; Howard A. Burris, Sarah Cannon Research Institute, Nashville, TN; Véronique Diéras, Institut Curie, Paris; Fabrice Andre, Institut Gustave Roussy, Villejuif, France; Nadia Harbeck, Interdisciplinary Breast Cancer, University of Cologne, Cologne; Nadia Harbeck, Breast Cancer University of Munich, Germany; Luca Gianni, San Raffaele Hospital, Milan; Diana Crivellari, Centro di Riferimento Oncologico, Istituto Nazionale Tumori, Aviano, Italy; Sanne L. de Haas, F. Hoffmann-La Roche, Basel, Switzerland. · Pubmed 24733796
  • Authors' Affiliations: Research Oncology, Departments of Biostatistics, Product Development Oncology, and Translational Oncology, Genentech, Inc., South San Francisco, California; Indiana University Simon Cancer Center, Indianapolis, Indiana; Institute Gustave Roussy, Villejuif; Department of Medical Oncology, Institut Curie, Paris, France; Sarah Cannon Research Institute, Nashville, Tennessee; Loyola University Medical Center, Maywood, Illinois; University of Munich, Munich, Germany; and Division of Medical Oncology, Centro di Riferimento Oncologico, Instituto Nazionale Tumori Aviano, Italy. · Pubmed 24097864
  • Sibylle Loibl, Sana Klinikum, Offenbach; Sibylle Loibl, Gunter von Minckwitz, Sanxing Guo, Stephan Gade, and Valentina Nekljudov, German Breast Group, Neu-Isenburg; Gunter von Minckwitz, Universitäts-Frauenklinik; Fariba Khandan, Agaplesion Markus Krankenhaus; Clemens Heinrichs, OptiPath, Frankfurt; Andreas Schneeweiss and Peter Sinn, Nationales Centrum für Tumorerkrankungen, Heidelberg; Stephan Paepke, Klinikum Rechts der Isar der Technischen Universität, München; Annika Lehmann, Berit Pfitzner, Judith L. Lindner, and Carsten Denkert, Charité Universitätsmedizin; Michael Untch, Helios-Klinikum, Berlin; Mahdi Rezai, Luisenkrankenhaus; Karel Dohnal, Centre for Pathology and Cytology, Düsseldorf; Dirk M. Zahm, SRH Waldklinikum, Gera; Holger Eidtmann, Universitäts-Frauenklinik, Kiel; Jens Huober, Universitäts-Frauenklinik, Ulm; Peter A. Fasching, Universitäts-Frauenklinik, Erlangen; August Dykgers, St Josef Hospital, Dortmund, Germany; Fabrice Andre, Institute Gustave Roussy, Villeueve, France; Christos Sotiriou, Institut Jules Bordet, Brussels, Belgium; and Sherene Loi, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Sibylle Loibl, Sana Klinikum, Offenbach; Sibylle Loibl, Gunter von Minckwitz, Sanxing Guo, Stephan Gade, and Valentina Nekljudov, German Breast Group, Neu-Isenburg; Gunter von Minckwitz, Universitäts-Frauenklinik; Fariba Khandan, Agaplesion Markus Krankenhaus; Clemens Heinrichs, OptiPath, Frankfurt; Andreas Schneeweiss and Peter Sinn, Nationales Centrum für Tumorerkrankungen, Heidelberg; Stephan Paepke, Klinikum Rechts der Isar der Technischen Universität, München; Annika Lehmann, Berit Pfitzner, Judith L. Lindner, and Carsten Denkert, Charité Universitätsmedizin; Michael Untch, Helios-Klinikum, Berlin; Mahdi Rezai, Luisenkrankenhaus; Karel Dohnal, Centre for Pathology and Cytology, Düsseldorf; Dirk M. Zahm, SRH Waldklinikum, Gera; Holger Eidtmann, Universitäts-Frauenklinik, Kiel; Jens Huober, Universitäts-Frauenklinik, Ulm; Peter A. Fasching, Universitäts-Frauenklinik, Erlangen; August Dykgers, St Josef Hospital, Dortmund, Germany; Fabrice Andre, Institute Gustave Roussy, Villeueve, France; Christos Sotiriou, Institut Jules Bordet, Brussels, Belgium; and Sherene Loi, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Pubmed 25199759
  • INSERM Unit U981, Institut Gustave Roussy, Villejuif, France. · Pubmed 24401929
2013
  • aINSERM Unit U981, Université Paris Sud, Gustave Roussy bDepartment of Medical Oncology, Gustave Roussy, Villejuif, France. · Pubmed 24097109
  • aInstitut National de la Santé et de la Recherche Médicale (INSERM) U981 bDepartment of Medical Oncology, Gustave Roussy Institute (IGR), Villejuif, France. · Pubmed 24097108
  • INSERM Unit U981 and Breast Cancer Unit, Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Pubmed 24074801
  • INSERM U981 "Identification of molecular predictors and new targets for cancer treatment", Gustave Roussy Cancer Institute, Villejuif, France. · Pubmed 23830798
  • Unité INSERM U753, Institut de Cancérologie Gustave Roussy, Villejuif, France. · Pubmed 23436798
  • INSERM Unit U981 and Université Paris Sud, Gustave Roussy Institute, 114 rue Edouard Vaillant, 94805 Villejuif, France. · Pubmed 23408207
  • Department of Breast Surgery, Institut Gustave Roussy, Villejuif, France. · Pubmed 23312273
2012
  • Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. · Pubmed 22840369
  • Department of Medicine, Institut Gustave Roussy, 94805 Villejuif, France. · Pubmed 22591913
  • Breast Cancer Unit, Department of Pathology, Institut Gustave Roussy, Villejuif, France. · Pubmed 22112967
2010
  • Department of Medical Oncology and INSERM Unit U981, Institut Gustave Roussy, Villejuif, France. · Pubmed 20943632
  • Laboratoire de Transfert Biologique et Oncologique, Marseille University France. · Pubmed 20827732
  • Department of Breast Oncology, Institut Gustave Roussy, Villejuif, France. · Pubmed 20740578
  • Department of Surgery, Breast Cancer Group, Institut Gustave Roussy, Villejuif, France. · Pubmed 20299317
  • Breast Cancer Translational Research Unit, UPRES EA03535, Université Paris XI, Institut Gustave Roussy, Villejuif, France. · Pubmed 20068563
  • Institut Gustave Roussy, U848, 94805 Villejuif, France. · Pubmed 20068181
2009
  • Département de Médecine, Comité de Pathologie Mammaire, Institut Gustave-Roussy, 39 Rue Camille-Desmoulins, 94800 Villejuif, France. · Pubmed 19696005
  • Institut de cancérologie Gustave-Roussy, 39, rue Camille Desmoulins, 94805, Villejuif cedex, France. · Pubmed 19399528
  • Research Translational Laboratory, Histocytopathology Unit, Gustave Roussy Institute, 39 rue Camille Desmoulins, Villejuif, France. · Pubmed 19347827
Probable:    Universite Paris 11 Sud      
2017
  • Medical Oncology Department, Institut Curie, PSL Research University, Paris, France. · Biostatistics Department, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille, Marseille. · Medical Oncology Department, Centre Paul Strauss, Strasbourg. · Medical Oncology Department, Gustave Roussy INSERM Unit U981, Université Paris Sud, Villejuif. · Medical Oncology Department, Institut Claudius Regaud, IUCT, Toulouse. · Medical Oncology Department, Centre François Baclesse, Caen. · Medical Oncology Department, Centre Antoine Lacassagne, Nice. · Medical Oncology Department, Institut du Cancer de Montpellier, Montpellier. · Medical Oncology Department, Centre Oscar Lambret, Lille. · Medical Oncology Department, Institut Curie, Saint Cloud. · Medical Oncology Department, Centre Léon Bérard, Lyon. · Medical Oncology Department, Centre Eugène Marquis, Rennes. · Medical Oncology Department, Institut de Cancérologie de l'Ouest, ICO Angers Nantes. · Medical Oncology Department, Institut Jean Godinot, Reims. · Medical Oncology Department, Centre Jean Perrin, Clermont Ferrand. · Medical Oncology Department, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris, Université Pierre et Marie Curie, Paris. · Centre Armoricain de Radiothérapie d'Imagerie médicale et d'Oncologie, Plérin. · Centre Catherine de Sienne, Nantes. · Pathology Department, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille, Marseille. · Aix-Marseille Université, Marseille. · R&D UNICANCER, UCBG, Paris. · Department of Medical Oncology, Centre de Recherche en Cancé rologie de Marseille, Institut Paoli-Calmettes, Marseille, France. · Pubmed 28177480
2016
  • Department of Biostatistics, International Drug Development Institute (IDDI), Louvain La Neuve, Belgium · Division of Hematology-Oncology, University of California, Los Angeles (UCLA), Los Angeles, USA. · Department of Medical Oncology, Institut Gustave Roussy, Université Paris Sud, Villejuif, France. · Department of Breast Oncology, Beijing 307 Hospital of PLA, Beijing, China. · Department of Drug Development, Sarah Cannon Research Institute, Nashville, USA. · Department of Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan. · Breast Surgery Clinic, Isarklinikum München, Munich, Germany. · Department of Scientific Development, Translational Research in Oncology (TRIO), Edmonton, Canada. · Pubmed 26861602
  • INSERM Unit U981, Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Centre Léon Bérard, Inserm U1052, Lyon, France. · Biostatistics Department, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. · Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Nantes, France. · Department of Medical Oncology, Gustave Roussy, Villejuif, France. · Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre, France. · Drug Development Department (DITEP), Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Centre François Baclesse, Caen, France. · R&D UNICANCER, Paris, France. · Bioinformatics core facility, Gustave Roussy, Villejuif, France. · Department of Medical Biology and Pathology, Translational research laboratory and biobank, Gustave Roussy, Villejuif, France. · Department of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy. · Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · Department of Medical Oncology, Institut Curie, Paris & Saint-Cloud, France. · Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France. · Department of Clinical Research, Centre Antoine Lacassagne, Nice, France. · Department of Medical Oncology, Institut du Cancer de Montpellier, Montpellier, France. · Department of Medical Oncology, Centre Oscar Lambret, Lille, France. · Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France. · Department of Medical Oncology, Centre Henri Becquerel, Rouen, France. · Department of Medical Oncology, Centre Eugène Marquis, Rennes, France. · Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France. · Department of Medical Oncology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. · UNICANCER Biobanking Center, Centre Léon Bérard, Lyon, France. · Department of Medical Oncology, Institut Bergonié, Université de Bordeaux, INSERM U916, Bordeaux, France. · EA7285, Versailles-Saint-Quentin-en-Yvelines University, Montigny-le-Bretonneux, France. · Pubmed 28027327
  • INSERM Unit U981, Gustave Roussy, Villejuif, France. Faculté de Médecine, Kremlin-Bicêtre, Université Paris Sud, France. · Department of Medical Biology and Pathology, Translational Research Laboratory and BioBank, Gustave Roussy, Villejuif, France. · Biostatistics Department, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. · INSERM Unit U981, Gustave Roussy, Villejuif, France. Drug Development Department (DITEP), Gustave Roussy, Villejuif, France. · Bioinformatics Core Facility, Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Nantes, France. · Department of Medical Oncology, Centre François Baclesse, Caen, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Medical Oncology, Centre Léon Bérard, Inserm U1052, Lyon, France. · R&D, UNICANCER, Paris, France. · INSERM Unit U981, Gustave Roussy, Villejuif, France. Faculté de Médecine, Kremlin-Bicêtre, Université Paris Sud, France. Drug Development Department (DITEP), Gustave Roussy, Villejuif, France. Department of Medical Oncology, Gustave Roussy, Villejuif, France. · INSERM Unit U981, Gustave Roussy, Villejuif, France. Department of Medical Biology and Pathology, Translational Research Laboratory and BioBank, Gustave Roussy, Villejuif, France. · INSERM Unit U981, Gustave Roussy, Villejuif, France. Faculté de Médecine, Kremlin-Bicêtre, Université Paris Sud, France. Department of Medical Oncology, Gustave Roussy, Villejuif, France. · INSERM Unit U981, Gustave Roussy, Villejuif, France. · Pubmed 27535334
  • Department of Surgery, Oncology and Gastroenterology, University of Padova, Via Giustiniani 2, 35121, Padua, Italy. · Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Via Gattamelata 64, 35128, Padua, Italy. · INSERM Unit U981, 114 rue E Vaillant, 94805, Villejuif, France. · Gustave Roussy, 114 rue E Vaillant, 94805, Villejuif, France. · Univ. Paris Sud, 63 rue Gabriel Péri, 94270, Le Kremlin-Bicêtre, France. · BGI-Shenzhen, Shenzhen, 518083, China. · Department of Medical Biology and Pathology, Gustave Roussy, 114 rue E Vaillant, 94805, Villejuif, France. · Laboratory of Translational Research and Biobank, Gustave Roussy, 114 rue E Vaillant, 94805, Villejuif, France. · Department of Medical Oncology, Gustave Roussy, 114 rue E Vaillant, 94805, Villejuif, France. · INSERM Unit U981, 114 rue E Vaillant, 94805, Villejuif, France. · Gustave Roussy, 114 rue E Vaillant, 94805, Villejuif, France. · Pubmed 26907767
  • Gustave Roussy, INSERM U981, Univ Paris-Sud, F 94805 Villejuif, France. · IRCIV, Univ Paris-Sud, F 94805 Villejuif, France. · Department of Biopathology, Gustave Roussy, F 94805 Villejuif, France. · Imaging and Cytometry Platform, Gustave Roussy, F 94805 Villejuif, France. · Faculté de Pharmacie, Université de Picardie Jules Vernes, 80000 Amiens, France. · Pubmed 26575022
2015
  • Equipe 11 labellisée Ligue contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. · INSERM, U1138, Paris, France. · Université Paris Descartes/Paris V, Sorbonne, Paris, France. · Université Pierre et Marie Curie/Paris VI, Paris, France. · Metabolomics and Cell Biology Platforms, Gustave Roussy Comprehensive Cancer Institute, Villejuif, France. · Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France. · Department of Women's and Children's Health, Karolinska University Hospital, Stockholm, Sweden. · Gustave Roussy Comprehensive Cancer Institute, Villejuif, France. · University of Paris Sud/Paris XI, Le Kremlin-Bicêtre, France. · INSERM, U1015, Villejuif, France. · Center of Clinical Investigations in Biotherapies of Cancer 507 (CICBT 507), Villejuif, France. · Pubmed 26444637
  • Department of Medical Oncology, Gustave Roussy and Université Paris Sud, 94800 Villejuif, France. · INSERM Unit U981, Gustave Roussy and Université Paris Sud, 94800 Villejuif, France. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, East Melbourne, VIC 3002, Australia. · Department of Biostatistics and Epidemiology, Gustave Roussy and Université Paris Sud, 94800 Villejuif, France. · Department of Medical Oncology and INSERM U916, Institut Bergonié, 229 Cours de l'Argonne, 33000, Bordeaux, France. · Pubmed 26196250
  • University of California, Los Angeles (UCLA), Los Angeles, CA, USA. Electronic address: · Department of Medical Oncology, Institut Gustave Roussy, Université Paris Sud, Villejuif, France. · Beijing 307 Hospital of PLA, Beijing, China. · Department of Breast Surgery, Cancer Hospital of Fudan University, Shanghai, China. · Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil. · Instituto Nacional de Enfermedades Neoplasicas, Surquillo, Lima, Peru. · Taipei Veterans General Hospital, National Yang Ming University, Taipei, Taiwan. · Department of Medical Oncology, Tumor Hospital of Harbin Medical University, Harbin, China. · Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, China. · Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China. · Department of Medical Oncology, University of Pretoria, Gauteng, South Africa. · Sarah Cannon Research Institute, Nashville, Tennessee, USA. · Department of Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan. · International Drug Development Institute, Louvain La Neuve, Belgium. · Translational Research in Oncology (TRIO), Paris, France. · Translational Research in Oncology (TRIO), Edmonton, Canada. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Novartis Pharma AG, Basel, Switzerland. · University of California, Los Angeles (UCLA), Los Angeles, CA, USA. · Pubmed 26092818
  • Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy. · Department of Medical Biology and Pathology, Gustave Roussy, Villejuif, France. · Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy. · INSERM, Unit U981, Gustave Roussy, Villejuif Department of Medical Oncology, Gustave Roussy, Villejuif. · INSERM, Unit U981, Gustave Roussy, Villejuif Department of Medical Oncology, Gustave Roussy, Villejuif Université Paris Sud, Villejuif, France. · INSERM, Unit U981, Gustave Roussy, Villejuif · Pubmed 25995301
  • Department of Medical Oncology, Gustave Roussy, Villejuif, France; INSERM Unit U981 and Université Paris Sud, Faculté de Medecine Kremlin Bicetre, Kremlin Bicetre, France. Electronic address: · Department of Medical Oncology, Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Institut Bergonie, Bordeaux, France. · Pubmed 25975636
2014
  • Department of Medical Oncology, INSERM Unit U981, Université Paris Sud, Institut Gustave Roussy, Villejuif, France. · Winship Cancer Institute of Emory University, Atlanta, GA, USA. · Cerrahpasa Medical Faculty, Department of Medicine, Division of Medical Oncology, Istanbul University, Istanbul, Turkey. · Kyoto University, Sakyo-ku, Kyoto, Japan. · Department of Medical Oncology, Cancer Hospital and Institute, Chinese Academy of Medical Sciences and Peking Union Medical College, Chaoyang District, Beijing, China. · Centre Hospitalier Universitaire du Sart-Tilman, Domaine Universitaire B35, Liège, Belgium. · NHO Osaka National Hospital, Chuou-ku, Osaka, Japan. · Cancer Care Centers of South Texas, San Antonio, TX, USA. · NYU Langone Arena Oncology, Lake Success, NY, USA. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA. · National Cancer Centre Singapore, Singapore. · Oncology Department, Military Hospital, Budapest, Hungary. · Orszagos Onkologiai Intezet, Budapest, Hungary. · Christie Hospital NHS Foundation Trust, Manchester, UK. · Sanatorio de la Providencia, Buenos Aires, Argentina. · Monash Medical Center, Moorabbin Hospital, Bentleigh East, VIC, Australia; Cabrini Brighton Hospital, Brighton, VIC, Australia. · Comprehensive Breast Health Center, RuiJin Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai, China. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Oncology Global Development, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Ospedale San Raffaele Scientific Institute, Milan, Italy. Electronic address: · Pubmed 24742739
  • Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France; INSERM Unit U981, Institut Gustave Roussy, Villejuif, France; Université Paris Sud, le Kremlin Bicêtre, France. Electronic address: · Departement de Cancerologie Medicale, Université Lyon 1, Centre Léon Bérard, Lyon, France. · INSERM Unit U981, Institut Gustave Roussy, Villejuif, France. · Institut de Cancérologie de l'Ouest/René Gauducheau, Nantes Saint Herblain, France. · Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France; INSERM Unit U981, Institut Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Institut Claudius Regaud, Department of Pathology, Toulouse, France. · Department of Translational Research, Institut Gustave Roussy, Villejuif, France. · Centre Léon Bérard, Lyon, France; Université Lyon 1, Lyon, France; ProfileXpert, SFR Lyon-Est, Lyon, France. · Department of Translational Research, Institut Curie, Paris, France. · Molecular Oncology Department, Institut Paoli Calmettes, Marseille, France. · Department of Medical Oncology, Institut Claudius Regaud, Toulouse, France. · Department of Medical Oncology, Institut Paoli Calmettes, Marseille, France. · Department of Medical Oncology, Centre François Baclesse, Caen, France. · Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France. · Department of Medical Oncology, Centre Oscar Lambret, Lille, France. · Department of Medical Oncology, Centre Eugène Marquis, Rennes, France. · Research and Development Unit, UNICANCER, Paris, France. · Department of Biostatistics, Institut Claudius Regaud, Toulouse, France. · Department of Medical Oncology, Institut Bergonié, Université de Bordeaux, INSERM U916, Bordeaux, France. · Pubmed 24508104
  • Breast Cancer Group, Institut Gustave Roussy, Villejuif, France. Electronic address: · Breast Cancer Group, Institut Gustave Roussy, Villejuif, France. · Breast Cancer Group, Institut Gustave Roussy, Villejuif, France; INSERM U981, Institut Gustave Roussy, Villejuif, France. · Breast Cancer Group, Institut Gustave Roussy, Villejuif, France; INSERM U981, Institut Gustave Roussy, Villejuif, France; Université Paris Sud, Le Kremlin Bicêtre, France. · Pubmed 24411195
  • Department of Medical Oncology, INSERM Unit U981, Université Paris Sud, Institut Gustave Roussy, Villejuif, France. · Ospedale San Raffele Scientific Institute, 20132 Milan, Italy. Electronic address: · Pubmed 24988930
2013
  • Department of Medical Oncology, INSERM Unit U981, Paris Sud University, Institut Gustave-Roussy, Villejuif, France. · Pubmed 23658459
2010
  • Breast Cancer Unit, Department of Medical Oncology, University Paris XI and Institut Gustave Roussy, Villejuif, France. · Pubmed 20975068
2009
  • Breast Medical Oncology Unit, Department of Radiation Therapy, Department of Pathology and Translational Research Unit (UPRES EA03535), Institut Gustave Roussy, University of Paris XI, Villejuif, France. · Pubmed 19939894
  • Translational Research Unit, UPRES03535, Paris Sud University, Orsay, France. · Pubmed 19147748
2017
  • Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ. · Pubmed 28777142
2016
  • From the University of Texas M.D. Anderson Cancer Center, Houston (G.N.H.), and Texas Oncology-Baylor Charles A. Sammons Cancer Center and the U.S. Oncology Network, Dallas (J.O.) - all in Texas; Davidoff Center, Rabin Medical Center, Tel Aviv University, Tel Aviv (S.M.S.), and Sheba Medical Center, Ramat Gan (S.P.-S.) - both in Israel; the Sarah Cannon Research Institute (H.A.B., D.Y.), Vanderbilt-Ingram Cancer Center (C.L.A.), and Tennessee Oncology (D.Y.) - all in Nashville; National Cancer Center Singapore, Singapore (Y.-S.Y.); Netherlands Cancer Institute and BOOG Study Center, Amsterdam (G.S.S.); Institut de Cancérologie de l'Ouest/René Gauducheau, Saint-Herblain (M.C.), Institut Gustave Roussy, Université Paris Sud, Villejuif (F.A.), University Hospital of Besançon, Besançon (C.V.), and Centre Léon Bérard, Lyon (T.B.) - all in France; Duke University Medical Center, Durham, NC (K.L.B.); Dana-Farber Cancer Institute, Boston (E.P.W.); University of Ulm, Ulm (W.J.), Onkologische Praxis, Velbert (A.N.), University of Tübingen, Tübingen (E.-M.G.), and Joint Practice for Interdisciplinary Oncology and Hematology, Freiburg (N.M.) - all in Germany; Tom Baker Cancer Centre, Calgary, AB, Canada (S.V.); University of Padua and Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy (P.C.); Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh (D.A.C.); Masaryk Memorial Cancer Institute, Brno, Czech Republic (K.P.); Florida Cancer Specialists-Sarah Cannon Research Institute, Fort Myers (L.L.H.); Breast Cancer Research Centre-Western Australia and Curtin University, Perth, Australia (A.C.); Department of Oncology, Vejle Hospital, Vejle, Denmark (E.J.); Arkhangelsk Clinical Oncology Dispensary, Arkhangelsk, Russia (O.B.); Hospital Universitario Virgen de la Victoria, Institute of Biomedical Research in Málaga, Málaga, Spain (E.A.); Oslo University Hospital, Oslo (E.W.); Virginia Cancer Specialists, Arlington (A.M.F.); Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan (L.-M.T.); Rainier Hematology-Oncology, Northwest Medical Specialties, Puyallup, WA (S.B.); Novartis Pharmaceuticals, East Hanover, NJ (F.X., M.M., C.G., S.H.); and Novartis Pharma, Basel, Switzerland (F.S.). · Pubmed 27717303
  • Fabrice André, Institut Gustav Roussy, INSERM Unit U981, Université Paris Sud, Villejuif, France; Sara Hurvitz and Dennis Slamon, University of California, Los Angeles, Los Angeles, CA; Angelica Fasolo, San Raffaele Scientific Institute, Milan, Italy; Ling-Ming Tseng, National Yang Ming University, Taipei, Taiwan; Guy Jerusalem, University of Liège, Liege, Belgium; Sharon Wilks, Cancer Care Center of South Texas, San Antonio, TX; Ruth O'Regan, University of Wisconsin Carbone Cancer Center, Madison, WI; Claudine Isaacs, Georgetown University, Washington DC; Masakazu Toi, Kyoto University, Sakyo-ku, Kyoto, Japan; Howard Burris, Sarah Cannon Research Institute, Nashville, TN; Wei He, Douglas Robinson, and Markus Riester, Novartis Institutes for BioMedical Research, Cambridge, MA; and Tetiana Taran and David Chen, Novartis Pharmaceuticals Corporation, East Hanover, NJ. · Fabrice André, Institut Gustav Roussy, INSERM Unit U981, Université Paris Sud, Villejuif, France; Sara Hurvitz and Dennis Slamon, University of California, Los Angeles, Los Angeles, CA; Angelica Fasolo, San Raffaele Scientific Institute, Milan, Italy; Ling-Ming Tseng, National Yang Ming University, Taipei, Taiwan; Guy Jerusalem, University of Liège, Liege, Belgium; Sharon Wilks, Cancer Care Center of South Texas, San Antonio, TX; Ruth O'Regan, University of Wisconsin Carbone Cancer Center, Madison, WI; Claudine Isaacs, Georgetown University, Washington DC; Masakazu Toi, Kyoto University, Sakyo-ku, Kyoto, Japan; Howard Burris, Sarah Cannon Research Institute, Nashville, TN; Wei He, Douglas Robinson, and Markus Riester, Novartis Institutes for BioMedical Research, Cambridge, MA; and Tetiana Taran and David Chen, Novartis Pharmaceuticals Corporation, East Hanover, NJ. · Pubmed 27091708
2013
  • aINSERM Unit U981, Université Paris Sud, Gustave Roussy bDepartment of Medical Oncology, Gustave Roussy, Villejuif, France. · Pubmed 24097109
  • INSERM Unit U981 and Université Paris Sud, Gustave Roussy Institute, 114 rue Edouard Vaillant, 94805 Villejuif, France. · Pubmed 23408207
2010
  • Breast Cancer Translational Research Unit, UPRES EA03535, Université Paris XI, Institut Gustave Roussy, Villejuif, France. · Pubmed 20068563
Probable:    INSERM Paris      
2017
  • Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France. · Department of Cancer Medicine, Gustave Roussy, Villejuif, France; Inserm U931, Cancer Biomarkers, Université Paris Saclay, Gustave Roussy, Villejuif, France. · Department of Cancer Medicine, Gustave Roussy, Villejuif, France; Inserm U931, Cancer Biomarkers, Université Paris Saclay, Gustave Roussy, Villejuif, France. Electronic address: · Pubmed 28400088
  • Medical Oncology Department, Institut Curie, PSL Research University, Paris, France. · Biostatistics Department, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille, Marseille. · Medical Oncology Department, Centre Paul Strauss, Strasbourg. · Medical Oncology Department, Gustave Roussy INSERM Unit U981, Université Paris Sud, Villejuif. · Medical Oncology Department, Institut Claudius Regaud, IUCT, Toulouse. · Medical Oncology Department, Centre François Baclesse, Caen. · Medical Oncology Department, Centre Antoine Lacassagne, Nice. · Medical Oncology Department, Institut du Cancer de Montpellier, Montpellier. · Medical Oncology Department, Centre Oscar Lambret, Lille. · Medical Oncology Department, Institut Curie, Saint Cloud. · Medical Oncology Department, Centre Léon Bérard, Lyon. · Medical Oncology Department, Centre Eugène Marquis, Rennes. · Medical Oncology Department, Institut de Cancérologie de l'Ouest, ICO Angers Nantes. · Medical Oncology Department, Institut Jean Godinot, Reims. · Medical Oncology Department, Centre Jean Perrin, Clermont Ferrand. · Medical Oncology Department, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris, Université Pierre et Marie Curie, Paris. · Centre Armoricain de Radiothérapie d'Imagerie médicale et d'Oncologie, Plérin. · Centre Catherine de Sienne, Nantes. · Pathology Department, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille, Marseille. · Aix-Marseille Université, Marseille. · R&D UNICANCER, UCBG, Paris. · Department of Medical Oncology, Centre de Recherche en Cancé rologie de Marseille, Institut Paoli-Calmettes, Marseille, France. · Pubmed 28177480
2016
  • Université Paris Saclay, institut Gustave-Roussy, département de médecine oncologique, Inserm U981, 114, rue Edouard-Vaillant, 94800 Villejuif, France. Electronic address: · Centre Léon-Bérard, département de cancérologie médicale, 28, rue Laënnec, 69008 Lyon cedex 08, France. · Université de recherche Paris, sciences et lettres, institut Curie, 26, rue d'Ulm, 75005 Paris, France. · Hôpital Saint-Louis, 1, avenue Claude-Vellefaux, 75010 Paris, France. · Institut Curie, Saint-Cloud, 35, rue Dailly, 92210 Saint-Cloud, France; Université Versailles-Saint-Quentin, 78180 Montigny-le-Bretonneux, France. · Université de Bordeaux, institut Bergonie, 229, cours de l'Argonne, 33000 Bordeaux, France. · Hôpital Tenon, université Paris-Sorbonne, Inserm U938, 4, rue de la Chine, 75020 Paris, France. · Institut universitaire du cancer-Toulouse oncopole, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France. · Centre Armoricain d'oncologie, Cario, 21, rue du Vieux-Séminaire, 22000 Saint-Brieuc, France. · Université de Montpellier, institut du cancer, IRCM U1194, 34298 Montpellier, France. · Institut de cancérologie de la Loire, 108 B, avenue Albert-Raimond, 42270 Saint-Priest-en-Jarez, France. · R&D Unicancer, 101, rue de Tolbiac, 75013 Paris, France. · Université Aix-Marseille, institut Paoli-Calmettes, Inserm U1068, 232, boulevard de Sainte-Marguerite, 13009 Marseille, France. · Université de Bourgogne, centre Georges-François-Leclerc, 1, rue du Pr-Marion, 21000 Dijon, France. · Centre Jean-Bernard, 9, rue Beauverger, 72000 Le Mans, France. · Université de Strasbourg, centre Paul-Strauss, 3, rue de la Porte-de-l'Hôpital, 67000 Strasbourg, France. · Université d'Auvergne, centre Jean-Perrin, 58, rue Montalembert, 63000 Clermont-Ferrand, France. · Institut d'oncologie de l'Ouest, Inserm U892, IRT-UN, 8, quai Moncousu, 44007 Nantes cedex, France. · Centre François-Baclesse, 3, avenue du Général-Harris, 14000 Caen, France. · Centre Catherine-de-Sienne, 2, rue Éric-Tabarly, 44202 Nantes, France. · CHU de Limoges, service d'oncologie médicale, 22, avenue Martin-Luther-King, 87000 Limoges, France. · Institut Sainte-Catherine, 250, chemin de Baignes-Pieds, 84918 Avignon cedex 9, France. · Ligue nationale contre le cancer, comité du Lot, 28, boulevard Gambetta, 46000 Cahors, France. · Europadonna France, 14, rue Corvisart, 75013 Paris, France. · Université de Lyon, 69000 Lyon, France; Université Lyon 1, 69100 Villeurbanne, France; Centre de recherche en cancérologie de Lyon, Inserm U1052, CNRS UMR5286, 69000 Lyon, France; Centre Léon-Bérard, 69008 Lyon, France. · Registre de Côte d'Or, centre Georges-François-Leclerc, 1, rue du Pr-Marion, 21000 Dijon, France. · Institut Gustave-Roussy, département d'imagerie médicale, 114, rue Edouard-Vaillant, 94800 Villejuif, France. · Université Paris Saclay, institut Gustave-Roussy, département de médecine oncologique, Inserm U981, 114, rue Edouard-Vaillant, 94800 Villejuif, France. · Université de recherche Paris, sciences et lettres, institut Curie, 26, rue d'Ulm, 75005 Paris, France; Institut Curie, Saint-Cloud, 35, rue Dailly, 92210 Saint-Cloud, France; Université Versailles-Saint-Quentin, 78180 Montigny-le-Bretonneux, France. · Pubmed 27473920
  • INSERM Unit U981, Gustave Roussy, Villejuif, France. Faculté de Médecine, Kremlin-Bicêtre, Université Paris Sud, France. · Department of Medical Biology and Pathology, Translational Research Laboratory and BioBank, Gustave Roussy, Villejuif, France. · Biostatistics Department, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. · INSERM Unit U981, Gustave Roussy, Villejuif, France. Drug Development Department (DITEP), Gustave Roussy, Villejuif, France. · Bioinformatics Core Facility, Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Nantes, France. · Department of Medical Oncology, Centre François Baclesse, Caen, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Medical Oncology, Centre Léon Bérard, Inserm U1052, Lyon, France. · R&D, UNICANCER, Paris, France. · INSERM Unit U981, Gustave Roussy, Villejuif, France. Faculté de Médecine, Kremlin-Bicêtre, Université Paris Sud, France. Drug Development Department (DITEP), Gustave Roussy, Villejuif, France. Department of Medical Oncology, Gustave Roussy, Villejuif, France. · INSERM Unit U981, Gustave Roussy, Villejuif, France. Department of Medical Biology and Pathology, Translational Research Laboratory and BioBank, Gustave Roussy, Villejuif, France. · INSERM Unit U981, Gustave Roussy, Villejuif, France. Faculté de Médecine, Kremlin-Bicêtre, Université Paris Sud, France. Department of Medical Oncology, Gustave Roussy, Villejuif, France. · INSERM Unit U981, Gustave Roussy, Villejuif, France. · Pubmed 27535334
  • Gustave Roussy, INSERM U981, Univ Paris-Sud, F 94805 Villejuif, France. · IRCIV, Univ Paris-Sud, F 94805 Villejuif, France. · Department of Biopathology, Gustave Roussy, F 94805 Villejuif, France. · Imaging and Cytometry Platform, Gustave Roussy, F 94805 Villejuif, France. · Faculté de Pharmacie, Université de Picardie Jules Vernes, 80000 Amiens, France. · Pubmed 26575022
2015
  • Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy. · Department of Medical Biology and Pathology, Gustave Roussy, Villejuif, France. · Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy. · INSERM, Unit U981, Gustave Roussy, Villejuif Department of Medical Oncology, Gustave Roussy, Villejuif. · INSERM, Unit U981, Gustave Roussy, Villejuif Department of Medical Oncology, Gustave Roussy, Villejuif Université Paris Sud, Villejuif, France. · INSERM, Unit U981, Gustave Roussy, Villejuif · Pubmed 25995301
  • Department of Medical Oncology, Gustave Roussy, Villejuif, France; INSERM Unit U981 and Université Paris Sud, Faculté de Medecine Kremlin Bicetre, Kremlin Bicetre, France. Electronic address: · Department of Medical Oncology, Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Institut Bergonie, Bordeaux, France. · Pubmed 25975636
2014
  • Department of Medical Oncology, INSERM Unit U981, Université Paris Sud, Institut Gustave Roussy, Villejuif, France. · Winship Cancer Institute of Emory University, Atlanta, GA, USA. · Cerrahpasa Medical Faculty, Department of Medicine, Division of Medical Oncology, Istanbul University, Istanbul, Turkey. · Kyoto University, Sakyo-ku, Kyoto, Japan. · Department of Medical Oncology, Cancer Hospital and Institute, Chinese Academy of Medical Sciences and Peking Union Medical College, Chaoyang District, Beijing, China. · Centre Hospitalier Universitaire du Sart-Tilman, Domaine Universitaire B35, Liège, Belgium. · NHO Osaka National Hospital, Chuou-ku, Osaka, Japan. · Cancer Care Centers of South Texas, San Antonio, TX, USA. · NYU Langone Arena Oncology, Lake Success, NY, USA. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA. · National Cancer Centre Singapore, Singapore. · Oncology Department, Military Hospital, Budapest, Hungary. · Orszagos Onkologiai Intezet, Budapest, Hungary. · Christie Hospital NHS Foundation Trust, Manchester, UK. · Sanatorio de la Providencia, Buenos Aires, Argentina. · Monash Medical Center, Moorabbin Hospital, Bentleigh East, VIC, Australia; Cabrini Brighton Hospital, Brighton, VIC, Australia. · Comprehensive Breast Health Center, RuiJin Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai, China. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Oncology Global Development, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Ospedale San Raffaele Scientific Institute, Milan, Italy. Electronic address: · Pubmed 24742739
  • Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France; INSERM Unit U981, Institut Gustave Roussy, Villejuif, France; Université Paris Sud, le Kremlin Bicêtre, France. Electronic address: · Departement de Cancerologie Medicale, Université Lyon 1, Centre Léon Bérard, Lyon, France. · INSERM Unit U981, Institut Gustave Roussy, Villejuif, France. · Institut de Cancérologie de l'Ouest/René Gauducheau, Nantes Saint Herblain, France. · Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France; INSERM Unit U981, Institut Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Institut Claudius Regaud, Department of Pathology, Toulouse, France. · Department of Translational Research, Institut Gustave Roussy, Villejuif, France. · Centre Léon Bérard, Lyon, France; Université Lyon 1, Lyon, France; ProfileXpert, SFR Lyon-Est, Lyon, France. · Department of Translational Research, Institut Curie, Paris, France. · Molecular Oncology Department, Institut Paoli Calmettes, Marseille, France. · Department of Medical Oncology, Institut Claudius Regaud, Toulouse, France. · Department of Medical Oncology, Institut Paoli Calmettes, Marseille, France. · Department of Medical Oncology, Centre François Baclesse, Caen, France. · Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France. · Department of Medical Oncology, Centre Oscar Lambret, Lille, France. · Department of Medical Oncology, Centre Eugène Marquis, Rennes, France. · Research and Development Unit, UNICANCER, Paris, France. · Department of Biostatistics, Institut Claudius Regaud, Toulouse, France. · Department of Medical Oncology, Institut Bergonié, Université de Bordeaux, INSERM U916, Bordeaux, France. · Pubmed 24508104
  • 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. [4] Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. [3] INSERM, U848, Villejuif, France. · 1] INSERM, U848, Villejuif, France. [2] Equipe 11 Labellisée par la Ligue Nationale Contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. [3] Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Department of Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France. [3] Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · Regina Elena National Cancer Institute, Rome, Italy. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U981, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Transgene S.A., Illkirch-Graffenstaden, France. · Laboratory for Genomics and Immunoregulation, Life and Medical Sciences (LIMES), University of Bonn, Bonn, Germany. · Laboratory of Experimental Dermatology, Department of Dermatology, University Hospital Bonn, Bonn, Germany. · Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy. · 1] SIB-Swiss Institute of Bioinformatics, Lausanne, Switzerland. [2] National Center of Competence in Research (NCCR) Molecular Oncology, Institut Suisse de Recherche Expérimentale sur le Cancer (ISREC), School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland. [3] Departement de Formation et Recherche, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. · Department of Pathology, Centre Claudius Regaud, Toulouse, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France. [4] Department of Medical Oncology, Hôpital Pitie Salpetriere, Paris, France. · Department of Medical Oncology, Hôpital Pitie Salpetriere, Paris, France. · Yale School of Medicine, New Haven, Connecticut, USA. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U1015, Villejuif, France. [3] Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Department of Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Pathology, Jean Perrin Center, EA 4677 ERTICa, University of Auvergne, Clermont-Ferrand, France. · 1] Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France. [2] INSERM, CRI-866 Faculty of Medicine, Dijon, France. [3] University of Burgundy, Dijon, France. · Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. · San Raffaele University and Scientific Institute, Milan, Italy. · 1] Center for Systems Biology, Massachusetts General Hospital, Boston, Massachusetts, USA. [2] Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts, USA. · Transgene S.A., Illkirch-Graffenstaden, France. · CNRS UMR5235, University Montpellier II, Place Eugène Bataillon, Montpellier, France. · Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA. · Queensland Institute of Medical Research, Herston, Queensland, Australia. · 1] Queensland Institute of Medical Research, Herston, Queensland, Australia. [2] School of Medicine, The University of Queensland, Herston, Queensland, Australia. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. [3] Department of Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France. [4] Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. [5] INSERM, U981, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] INSERM, U848, Villejuif, France. [3] Université Paris Descartes, Sorbonne Paris Cité, Paris, France. [4] Metabolomics Platform, Gustave Roussy Cancer Campus, Villejuif, France. [5] Pôle de Biologie, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France. [2] Université Paris Saclay, Faculté de Médecine, Le Kremlin Bicêtre, France. [3] Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France. · Pubmed 25344738
  • Breast Cancer Group, Institut Gustave Roussy, Villejuif, France. Electronic address: · Breast Cancer Group, Institut Gustave Roussy, Villejuif, France. · Breast Cancer Group, Institut Gustave Roussy, Villejuif, France; INSERM U981, Institut Gustave Roussy, Villejuif, France. · Breast Cancer Group, Institut Gustave Roussy, Villejuif, France; INSERM U981, Institut Gustave Roussy, Villejuif, France; Université Paris Sud, Le Kremlin Bicêtre, France. · Pubmed 24411195
  • Department of Medical Oncology, INSERM Unit U981, Université Paris Sud, Institut Gustave Roussy, Villejuif, France. · Ospedale San Raffele Scientific Institute, 20132 Milan, Italy. Electronic address: · Pubmed 24988930
2013
  • Department of Medical Oncology, INSERM Unit U981, Paris Sud University, Institut Gustave-Roussy, Villejuif, France. · Pubmed 23658459
2017
  • Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ. · Pubmed 28777142
2016
  • Fabrice André, Institut Gustav Roussy, INSERM Unit U981, Université Paris Sud, Villejuif, France; Sara Hurvitz and Dennis Slamon, University of California, Los Angeles, Los Angeles, CA; Angelica Fasolo, San Raffaele Scientific Institute, Milan, Italy; Ling-Ming Tseng, National Yang Ming University, Taipei, Taiwan; Guy Jerusalem, University of Liège, Liege, Belgium; Sharon Wilks, Cancer Care Center of South Texas, San Antonio, TX; Ruth O'Regan, University of Wisconsin Carbone Cancer Center, Madison, WI; Claudine Isaacs, Georgetown University, Washington DC; Masakazu Toi, Kyoto University, Sakyo-ku, Kyoto, Japan; Howard Burris, Sarah Cannon Research Institute, Nashville, TN; Wei He, Douglas Robinson, and Markus Riester, Novartis Institutes for BioMedical Research, Cambridge, MA; and Tetiana Taran and David Chen, Novartis Pharmaceuticals Corporation, East Hanover, NJ. · Fabrice André, Institut Gustav Roussy, INSERM Unit U981, Université Paris Sud, Villejuif, France; Sara Hurvitz and Dennis Slamon, University of California, Los Angeles, Los Angeles, CA; Angelica Fasolo, San Raffaele Scientific Institute, Milan, Italy; Ling-Ming Tseng, National Yang Ming University, Taipei, Taiwan; Guy Jerusalem, University of Liège, Liege, Belgium; Sharon Wilks, Cancer Care Center of South Texas, San Antonio, TX; Ruth O'Regan, University of Wisconsin Carbone Cancer Center, Madison, WI; Claudine Isaacs, Georgetown University, Washington DC; Masakazu Toi, Kyoto University, Sakyo-ku, Kyoto, Japan; Howard Burris, Sarah Cannon Research Institute, Nashville, TN; Wei He, Douglas Robinson, and Markus Riester, Novartis Institutes for BioMedical Research, Cambridge, MA; and Tetiana Taran and David Chen, Novartis Pharmaceuticals Corporation, East Hanover, NJ. · Pubmed 27091708
2013
  • INSERM Unit U981 and Université Paris Sud, Gustave Roussy Institute, 114 rue Edouard Vaillant, 94805 Villejuif, France. · Pubmed 23408207
  • Institut National de la Santé et de la Recherche Médicale (INSERM) U981, Paris, France. · Pubmed 23358685
  • Département de Biochimie, AP-HP, Hôpital Saint-Louis, Institut Universitaire d'Hématologie, CNRS UMR7212/INSERM U944/University Paris Diderot, Sorbonne Paris Cité, Paris, France. · Pubmed 22886769
2010
  • INSERM/CNRS/University Paris 7, UMR 944/7212, Hôpital Saint Louis, 1, av Claude Vellefaux, 75 475 Paris Cedex 10, France. · Pubmed 20228131
Show More